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Abstract 
 
 Campylobacteriosis is caused by the gram-negative bacteria Campylobacter and 
is a leading cause of gastrointestinal illness worldwide.  In the United States an estimated 
2.4 million cases occur annually with approximately $8.0 billion in associated costs.  Due 
to the high cost of morbidity, understanding the epidemiology and risk factors of 
campylobacteriosis is important.  It is unclear if the prevalence of campylobacteriosis is 
higher or lower in East Tennessee than other parts of the state or country or if the clinical 
characteristics of patients in the area are similar to the rest of the country.  Therefore, the 
purpose of the study was to describe clinical and epidemiological characteristics of 
campylobacteriosis patients in East Tennessee to assist in health planning to control 
campylobacteriosis.  Data from the Foodborne Disease Active Surveillance Network was 
analyzed for 2003-2006 in 16 counties in East Tennessee. The data was first assessed for 
its quality, then descriptive statistics were calculated and spatial and temporal patterns of 
reported cases and risk factors were assessed.  The overall error rate in the data quality 
analysis was 6.5% although in the last year of the study it was only 2.6%.  The mean 
annual prevalence of campylobacteriosis in East Tennessee was 10.4 cases per 100,000 
population, which was 1.6 times higher than all of Tennessee (7.4 cases/100,000).  
Grainger and Jefferson Counties had higher age- and sex-adjusted prevalence estimates 
than the region and nation.  It is yet unclear why this region has a higher prevalence of 
campylobacteriosis than the rest of the nation.  The highest age-specific prevalence (41.6 
cases/100,000) was observed in children under 5.  Disease prevalence was consistently 
higher in the summer months compared to the other seasons.  The median age of patients 
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was lower in the most rural counties.  More patients in East Tennessee were hospitalized 
than the rest of the nation.  The most commonly reported risk factors were animal and 
raw meat exposure.  Improvement in data collection and entry is necessary to improve the 
quality and application of this surveillance data.  Educational efforts on proper hygiene 
following animal handling, and proper well protection and disinfection should be targeted 
at high risk groups.   
 vi 
Preface 
 
 Unless otherwise specified, Campylobacter and Campylobacter spp. refer to C. 
jejuni and C. coli, the most common species identified in human disease.  Tables and 
figures follow the page on which they are first referenced. 
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1.0 Introduction  
 Campylobacteriosis is caused by the gram-negative bacteria Campylobacter.  
Members of the Campylobacter species are small, non-spore forming, gram-negative 
bacteria that have a characteristic curved, S-shape or spiral morphology[1].  They were 
first observed and described in 1886 but were first cultured in 1977[2]. Campylobacter 
jejuni and Campylobacter coli exhibit a similar clinical course of enteric disease and are 
therefore often grouped together in descriptions of disease characteristics.  An estimated 
2.4 million people suffer from campylobacteriosis each year in the United States; 13,000 
of these patients require hospitalization and 124 die[3].  The average patient misses 3.8 
days of work or school due to campylobacteriosis[4], but chronic sequelae can increase 
this number.  It is estimated that campylobacteriosis costs $8 billion a year in the United 
States[5], from lost wages and medical expenses related to the primary infection and any 
secondary complications.   
 Of all human Campylobacter infections, it is estimated that 85 to 99% are caused 
by C. jejuni and 5 to 10% by C. coli with C. fetus making up the remainder[6, 7].  
Infection caused by C. jejuni or C. coli results in acute enteritis with clinical courses that 
are hard to differentiate from those of other bacterial pathogens that cause acute 
gastrointestinal infections such as Salmonella or Escherichia coli.  Common symptoms 
are diarrhea (which may be bloody), nausea, fever, headache, myalgia and vomiting[8].  
Most cases are self-limiting but complications can occur.  These include reactive arthritis, 
or Guillain-Barré syndrome (observed in 1 out of 1000 campylobacteriosis patients)[9].  
Campylobacter fetus rarely causes enteritis although it has been isolated in systemic 
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blood infections.  It induces fever and can disseminate to numerous tissues such as the 
vascular endothelium, bones, and joints.  Complications of C. fetus infection may include 
meningitis, endocarditis, pneumonia, thrombophlebitis, septicemia, arthritis, and 
peritonitis[10]. 
 Commonly identified risk factors for human infection with C. jejuni and C. coli 
are chicken consumption or handling, international travel and animal exposure[11-14].  
In all exposure cases, the bacteria must be ingested in some form.  Campylobacter spp. 
are zoonotic and also infect household pets such as dogs and cats as well as livestock 
such as poultry and cattle and wild animals as well.  Many animals remain asymptomatic 
while infected but are still able to shed the bacteria in their feces.  Due to this, poor 
hygiene following any animal contact may result in infection.  Water can become 
contaminated by fecal run off which is also an important source of infection[15].  
 Campylobacter is the most common bacterial cause of diarrhea in the United 
States[3] and many other developed countries[16, 17].  The overall reported incidence 
varies worldwide, depending on the reporting practices, healthcare systems, risk factor 
distributions and hygiene levels in each country.  The reported incidence of 
campylobacteriosis ranges from 300-396 per 100,000 in New Zealand[18, 19] to 12.7 per 
100,000 in the United States[20].  These incidence figures only include the patients who 
sought medical care for their illness and on whom laboratory tests were conducted.  Due 
to this under-reporting, the true incidence of campylobacteriosis is most likely higher 
than the figures reported in the United States and other countries worldwide. 
 The state of Tennessee belongs to the Foodborne Active Surveillance Network 
(FoodNet) which conducts active surveillance for all foodborne pathogens, including 
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Campylobacter.  Under the active surveillance, every positive laboratory report for 
Campylobacter must be reported to the health department.  Additionally the health 
departments also conduct routine reviews of all the diagnostic laboratories in their 
jurisdiction to ensure all cases that are detected are reported in a timely fashion.  After a 
case is identified, a health department representative contacts the patient to collect 
additional data.  
 The incidence of campylobacteriosis in Tennessee is 7.4 per 100,000[20], but 
public health officials in East Tennessee (16 counties in the eastern portion of the state) 
have noticed that the incidence in this region appears to be higher[21] than the rest of the 
state of Tennessee.  It is unclear if the incidence in East Tennessee is truly higher than the 
rest of the state, or if there is a reason for the increased prevalence in the region.  It is also 
unclear if the clinical characteristics of the patients in this region are similar to the rest of 
the country.  This study is designed to determine the characteristics and risk factors 
among the cases of campylobacteriosis reported in East Tennessee.  Understanding the 
disease characteristics specific to the region can help to improve disease control and 
prevention strategies.  Demographic characteristics of reported cases will be assessed to 
identify high risk groups. The most commonly reported risk factors and clinical 
symptoms reported by the patients will be identified.  Geographical and temporal patterns 
and any association between geographic location, risk factors, clinical symptoms and 
socioeconomic determinants of health will be investigated.   By understanding the most 
common risk factors in the study area, the regional and local health departments will be 
able to better implement health programs to reduce future disease occurrence. 
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2.0 Literature Review 
2.1 Etiology 
 The genus Campylobacter is a member of the division Proteobacteria, class 
Epsilobacteria, order Campylobacterales, family Campylobacteraceae[22].  This family 
is made up of gram-negative bacteria that are primarily commensals or parasites of 
humans, domestic animals[23], and wild mammals. 
 Members of the Campylobacter species are small, non-spore forming, gram-
negative bacteria that have a characteristic curved, S-shape or spiral morphology[1]  
They are 0.2 to 0.9 µm wide and 0.5 to 5.0µm long with one or more spirals.  Cells have a 
single polar unsheathed flagellum, at one or both ends, that is used for motility[24].  
Some species, such as C. gracilis are non-motile.  The flagella may be up to 2-3 times the 
length of the cells[22].    Campylobacters were first observed and described in 1886 by 
Theodor Escherich as non-culturable spiral-shaped bacteria that were isolated from the 
intestinal contents of 16 of 17 children who died of diarrheal disease[25].  Escherich 
observed what he described as a “vibrionen” numerous times in the feces of human 
neonates and kittens with diarrhea[26].  While it is not certain that what Escherich 
described were indeed Campylobacters, their morphology, failure to grow on solid 
media, and association with enteric illness all seem to suggest that they were indeed 
Campylobacters.  In 1906, McFadyean and Stockman isolated an unknown spiral bacteria 
from sheep experiencing epizootic abortions [27].  Due to their curved, Vibrio-like 
appearance (similar to members of the genus Vibrio), the bacteria were given the name 
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Vibrio fetus in 1919 by Theobold Smith who was investigating infectious abortions in 
cattle[28].  Another species of Vibrio was identified in 1931 by F.S. Jones who was 
investigating infectious diarrhea in cattle, he named it Vibrio jejuni [29].  In 1963, Sebald 
and Véron noted that V. fetus and V. jejuni differed from the classical cholera Vibrios. 
They discovered that V. fetus and V. jejuni have a lower guanine plus cytosine (G plus C) 
DNA content compared to other Vibrios, and are unable to ferment carbohydrates[30].  
Due to these differences, a new genus Campylobacter (meaning “a curved rod”) was 
created. 
 Campylobacter species are considered microaerophillic because they grow best in 
atmosphere that contains only 3-15% oxygen, although some will grow under aerobic or 
anaerobic conditions, when necessary[22].  For energy, Campylobacters use amino acids 
or tricarboxylic acid cycle intermediates, such as α-ketoglutarate, succinate or fumarate.  
However all strains are not able to metabolize the same carbon sources[31].  All 
Campylobacter species will grow at 35 - 37°C but thermophillic species (C. jejuni C. 
coli, C. lari and C. upsaliensis) grow best at 42°C[24].  Table 2.1 shows all species of 
Campylobacter and their phenotypic characteristics[32].   
 Species that are important in human infections are C. jejuni, C. coli, C. fetus, and 
to a lesser degree C. lari and C. upsaliensis.  The primary species identified in 
gastrointestinal illness are C. jejuni and C. coli; they are responsible for an estimated 90-
99% and 5-10%, respectively, of human Campylobacter infections. 
 C. fetus can be broken down into two subspecies, C. fetus subsp. fetus and C. fetus 
subsp. venerealis. C. fetus subsp. fetus primarily causes abortion in sheep and 
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Table  2.1: Phenotypic characteristics differentiating Campylobacter species 
Species Catalase Nitrate 
reduction 
Nitrite 
reduction 
H2S 
production 
(TSI)* 
Hippurate 
hydrolysis 
Indoxyl 
acetate 
hydrolysis 
Growth at : 
 
25 °C   42 °C 
Growth 
in 1% 
glycine 
Alkaline 
phosphatase 
Susceptibility to:  
 
    NA†             C 
GC‡ 
content 
(mol %) 
Campylobacter coli + + - - - + - + + v S R 30+33 
Campylobacter concisus - + + + + - - + + v R R 37+41 
Campylobacter curvus - + + + - + - + + ND S ND 45+46 
Campylobacter fetus subsp. 
fetus 
+ + - - - - + - + - R S 33+35 
Campylobacter fetus subsp. 
venerealis 
+ + - - - - + - - - R S 33+34 
Campylobacter gracilis - + + ND ND ND ND ND ND ND R ND 44+46 
Campylobacter helveticus - + ND - - + - + + - S S 34 
Campylobacter hyoilei (C. coli) + + + + - ND ND v + ND S R 35 
Campylobacter hyointestinalis 
subsp. hyointestinalis 
+ + - + - - v + + v R S 33+36 
Campylobacter jejuni subsp. 
doylei 
+ - - - v + - - + + S S 30+31 
Campylobacter jejuni subsp. 
jejuni 
+ + - - + + - + + + S R 30+33 
Campylobacter lanienae + + + - - - - + - + R R 36 
Campylobacter lari + + - - - - - + + - R R 30+32 
Campylobacter mucosalis - + + + - - - + + v R S 36+38 
Campylobacter rectus - + + + - + - w + ND S ND 45+46 
Campylobacter showae + + + + - + - + v - R S 44+46 
- + + + - - - + + - R S 29+30 Campylobacter sputorum bv. 
bubulus 
             
+ + + + - - - + + v R S 30+32 Campylobacter sputorum bv. 
fecalis 
             
- + + + - - - + + ND S S 30+31 Campylobacter sputorum bv. 
sputorum 
             
Campylobacter upsaliensis w/- + - - - + - + v v S S 32+36 
*TSI: Triple Sugar Iron test, † NA: nalidixic acid; C: cephalothin, ‡GC: Guanine-Cytosine content 
Test results: +, positive reaction; -, negative reaction; w, weak reaction; v, variable reaction; R, resistant; S, sensitive; ND, not determined 
Table adopted from: Logan, J.M., et al., Campylobacter lanienae sp. nov., a new species isolated from workers in an abattoir. Int J Syst Evol Microbiol, 2000. 50 Pt 2: p. 865-72. 
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sporadically in cattle, but has also been isolated from human aborted fetuses in rare 
occasions.  In humans, C. fetus subsp. fetus causes systemic infection and occasionally 
gastrointestinal infections[22]. C. fetus subsp. venerealis can cause abortion and 
infertility in cattle.  Unlike C. fetus subsp. fetus, C. fetus subsp. venerealis is unable to 
multiply in the intestinal tract of humans and other animals[33]. 
 C. upsaliensis has frequently been isolated from canine and feline fecal specimens 
of both healthy and diarrheic animals[34-37].  It is classified as thermotolerant since only 
80% of isolates tested have been shown to grow at 42°C[38, 39], unlike the thermophillic 
species where all strains can grow at 42°C.  C. upsaliensis has been isolated from human 
fecal samples but infection with this species appears to cause less vomiting and 
nausea[39].  Unlike other Campylobacter species that cause enteric infections, C. 
upsaliensis has been associated with hemolytic uremic syndrome, a serious complication 
affecting the kidneys[40]. Since C. upsaliensis is sensitive to the antibiotics used in 
selective media for the routine culture of C. jejuni and C. coli, other techniques must be 
used to isolate this species.  C. upsaliensis can be isolated by filter techniques, but these 
methods are not routine in most diagnostics laboratories and are usually not requested by 
the physician ordering the stool culture.  Due to the decreased ability to isolate the 
bacteria, the burden of human disease from C. upsaliensis  has been difficult to estimate 
and is currently unknown[41]. 
 C. lari has been isolated from the intestines of shore birds in Sweden[42], water 
samples in New Zealand[43], shellfish in the Netherlands [44], and pigs in Texas[45]. It 
has been also been identified as a cause of bacteremia in humans[46, 47] but the true 
burden of disease is unknown.  C. lari was originally described with the phenotypic 
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characteristic of nalidixic acid resistance, but several strains have been isolated that are 
nalidixic acid susceptible.  This is important since the phenotypic response to nalidixic 
acid is often used to differentiate between species and this could lead to misidentification 
of species.  The nalidixic acid resistance is also important because nalidixic acid is the 
basis for the quinolone class antibiotics and fluoroquinolones are often the antibiotic of 
choice for treating Campylobacter infections[48, 49].  Although the current burden of 
disease from lari is low, more campylobacteriosis treatment failures could occur if the 
burden of disease due to C. lari increases and the empiric treatment of 
campylobacteriosis with fluoroquinolones is continued. 
2.2 Campylobacter Survival in the Environment 
 In order to survive long enough to be passed from one host to another, 
Campylobacters must endure stress factors such as exposure to oxygen, lower 
temperatures and desiccation.  As such they have developed mechanisms to survive in 
different environments until the bacteria can find a new host to colonize.   
 One survival mechanism involves the ability to enter a viable but nonculturable 
(VBNC) state[50].  Campylobacter cells transform from a motile spiral form to a coccoid 
form when they are subjected to unfavorable conditions such as low nutrient availability 
or incubation at temperatures outside the optimum growth temperature[51].  During this 
state, Campylobacter does not undergo DNA replication or protein synthesis[52-54], but 
it is believed that proteins are synthesized when the cells initiate the VBNC state[55].  
While experimental results are not always comparable (most likely due to strain 
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variations) VBNC Campylobacter cells have been resuscitated in animals in the 
laboratory[56-59], from aquatic environments[60], and after treatment with acid[61].  
Cells can be resuscitated up to 30 days after entering the VBNC state[60].    
 The formation of biofilms is another technique by which Campylobacter spp. can 
survive in extreme conditions.  A biofilm is composed of microcolonies of organisms, 
including bacteria, fungi, and protozoa, bound together by an extracellular matrix that 
provides a microenvironment separate from outside low nutrient and hostile 
conditions[62].   Biofilms are widely distributed in the environment and occur in most 
public water supplies and plumbing systems[63].  C. jejuni has been isolated from 
biofilms in aquatic environments and on stainless steel[63, 64].  Depending on the 
incubation temperature and microbial make up of the biofilm, C. jejuni has been 
documented to survive for 42 days in that environment[63].  Lower temperatures (4°C 
instead of 22°C) have been shown to lengthen the time that Campylobacter spp. can 
survive in aqueous environments[63]. 
 Campylobacter spp. has been isolated from surface water sources in the USA[65], 
UK[66, 67] and New Zealand[68].  The presence of Campylobacter in these water 
sources may be due to fecal run off.    Studies have shown that C. jejuni is capable of 
surviving in manure spread on grass for up to 63 days depending on the type of manure 
and animal source[69].  The longest Campylobacter survival time was recorded for dairy 
cattle slurry or liquid waste and beef cattle solid waste.  Pig slurry and sheep solid waste 
had the shortest survival times at only 16 days, while Campylobacter survived in poultry 
solid waste was 42 days.  Another study found that when the solid manure is stored in 
heaps the survival time is decreased to 2-4 days due to the heat in the center of the 
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heap[70].  The same study also showed that Campylobacter survived about half as long 
when spread on sandy soil compared to clay soil. 
 It has been estimated that up to 80% of retail chickens for sale in the United States 
are contaminated with Campylobacter spp.[71].  The meat most likely becomes 
contaminated after evisceration in the poultry processing plant due to cross 
contamination.  C. jejuni have been reported to have better survival rates on poultry meat 
with the skin intact compared with skinless meat[72].  Under normal refrigeration 
conditions, all meat types contained enough bacteria for an infectious dose for 
humans[72].   
 It has also been shown that Campylobacter spp. can be isolated from kitchen 
surfaces even after cleaning with detergent and hot water[73].  Authors of one study were 
able to isolate viable bacterial cells from beech and polypropylene cutting boards up to 2 
hours after inoculation[74].  The ability of C. jejuni to survive even a few hours on 
kitchen surfaces provides ample time for cross contamination to other foods.  It has also 
been shown that C. jejuni is able to survive for 24 hours on strawberries stored at room 
temperature and for 72 hours on cantaloupe stored at 7°C[75]. 
2.3 Clinical Course 
 Infection with Campylobacter spp. can result in several clinical manifestations.  
Human volunteer studies have shown that asymptomatic infections occur[76].  The most 
common clinical manifestation is enteric, resulting in acute diarrheal disease.  Enteric 
infections can sometimes lead to systemic infections if the bacteria invade the intestinal 
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cells and cross into the bloodstream.  Systemic infection is characterized by fever and 
joint pain[10].   Post infection complications of enteric illness include Guillain-Barré 
syndrome (GBS) and reactive arthritis[9]. 
2.3.1 Enteric Infections 
 Campylobacter infection causes acute diarrheal disease with clinical symptoms 
that are similar to those of other bacterial pathogens that cause acute gastrointestinal 
infections.  The most common presentation is acute enteritis.  Symptoms caused by C. 
jejuni and C. coli usually start with abrupt cramping pain in the abdomen that is quickly 
followed by diarrhea. Approximately 30% of the patients experience a prodrome of fever, 
headache, myalgia, dizziness, anorexia or malaise prior to the onset of diarrhea[1, 11, 
77].  The prodromal symptoms appear 12-24 hours prior to intestinal symptoms and this 
has been shown to indicate a more severe clinical course compared to patients who 
experience diarrhea first [78].  Diarrhea can vary from loose stools to stools that are 
profuse and watery, bloody, bile stained or slimy.  In descriptive reports of outbreaks, the 
most frequently reported symptoms are diarrhea and abdominal pain.  In Denmark, 95% 
of patients reported diarrhea and 86% reported abdominal pain[79].   Similarly, in two 
different outbreaks in Spain (2001 and 2003), diarrhea was reported by 100% and 93.6% 
of afflicted patients and abdominal pain was reported by 62.5% and 89.6% of patients, 
respectively [80, 81].  In surveys of emergency room patients, it was shown that more 
than 50% had 10 or more bowel movements a day[78].  Nausea is commonly reported but 
vomiting is reported less often than nausea[78, 82]. The duration of symptoms may last 
for 1-7 days or longer depending on the virulence of the species and or strain and the 
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immunological status of the patient[83].  On average, patients remain ill for 1-4 days but 
a study in Denmark found the median duration of all illness to be 10 days[11].     
 Using data from 17 point source outbreaks, the average incubation period was 
estimated to be 3.2 days, with a range of 18 hours to 8 days [8].  The authors of that study 
reported that the upper and lower bounds of the range may have actually been sporadic 
cases that were not actually part of the true outbreaks investigated.  Outbreak data is 
usually used when calculating the incubation period since it is normally difficult to 
pinpoint the source of infection in sporadic cases.  The Centers for Disease Control 
reports the average incubation period to be 2-5 days with a range of 2-10 days [84].  This 
slightly longer incubation period can be useful in separating Campylobacter from other 
gastrointestinal bacterial pathogens.  Other common pathogens that cause diarrhea, 
abdominal cramps and fever are nontyphoidal Salmonella, enterotoxigenic E. coli, and 
Shigella; these bacteria have average incubations periods of 6-48 hours, 6-48 hours and 
2-4 days, respectively. 
 A re-occurrence of symptoms is reported by 15-25% of patients whose recurring 
symptoms are severe enough to cause them to revisit their physician[8].  The rate of 
relapse may be higher since not all cases will revisit their physician for the same illness if 
their symptoms are mild.  The clinical course of the relapse is normally characterized by 
abdominal pain and may vary from a relatively mild gastroenteritis to an enterocolitis 
with bloody diarrhea, lasting for several weeks[85].   
 Patients will continue to shed Campylobacters in the feces for several weeks after 
recovery.  Some studies have shown that convalescent shedding period may be reduced if 
the antibiotics are administered early in the clinical disease course[86].  A meta analysis 
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of 11 double-blind studies of antibiotic use for the treatment of Campylobacter enteritis 
showed that the duration of intestinal symptoms was only shortened by 1.3 days with 
antibiotic use[86].  The same study showed that the duration of diarrhea was twice as 
long if the patient waited more than 3 days to seek medical treatment.  Another study 
found that the average patient will wait 4 or more days before seeking medical care[87].  
This delay in seeking medical care prolongs disease duration and may limit the 
usefulness of antibiotic treatment. 
2.3.2 Systemic Infections 
 Campylobacters are invasive bacteria that are able to translocate and reach the 
blood stream; however bacteremia in human Campylobacter enteritis patients is rarely 
reported.  A study in England found an average bacteremia rate of 1.5 cases of 
bacteremia per 1,000 intestinal infections, with a high degree of variability associated 
with age[88].  Elderly patients (over 65 years of age) had the highest rate of 5.9 per 1,000 
intestinal infections while young children ages 1-4 had the lowest rate at 0.3 per 1000 
intestinal infections[88].  Campylobacter fetus rarely causes enteritis and it has been 
isolated more frequently in systemic blood infections.  It induces fever and can 
disseminate to numerous tissues such as the vascular endothelium, bones, and joints.  
Complications from C. fetus infections can include meningitis, endocarditis, pneumonia, 
thrombophlebitis, septicemia, arthritis, and peritonitis[10]. 
2.3.3 Post-Infection Complications 
 Although most cases of campylobacteriosis are self-limiting, complications such 
as reactive arthritis or Guillain-Barré syndrome (GBS) have been documented following 
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infection.  However, reactive arthritis can follow infection by other intestinal bacteria 
such as Salmonella.  The frequency of documented joint pain following Campylobacter 
infection ranges from <1%[77] to19.9%[11].  This percentage depends on the prevalence 
of the Human Leukocyte Antigen B*27 (HLA B27) tissue antigen in the population 
surveyed; it can range from 0-50%[89].  HLA B27 is a surface antigen on the B locus of 
the major histocompatibility complex and presents antigens to T cells; it has been 
strongly associated with certain autoimmune diseases.  Patients with the antigen have a 
strong predisposition to reactive arthritis.  In most cases the joint pain lasts a few weeks 
to months and almost all result in a complete recovery[8].  Other local complications 
such as appendicitis, peritonitis, cholecystitis, hepatitis or pancreatitis may occur but are 
rare. 
 Guillain-Barré syndrome is an autoimmune-mediated disorder of the peripheral 
nervous system.   Affected patients will rapidly develop progressive weakness in their 
limbs and respiratory muscles and a loss of reflexes.  While the disease is generally self-
limiting, up to 20% of patients require mechanical ventilation for a portion of their 
recovery[90, 91] and 15-20% are left with severe neurological deficits[92-94].  
Campylobacter enteritis is reported as the most frequent antecedent event for GBS 
accounting for 30-40% of all GBS cases[95, 96].  Of patients who develop GBS after 
campylobacteriosis, the GBS symptoms normally develop 1-3 weeks after recovery from 
their gastrointestinal symptoms.  Some studies have suggested that patients who develop 
GBS after Campylobacter infection may have a more severe course of GBS than those 
who develop GBS from other causes[97].   One study found that on average, 1 out of 
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every 1000 patients with C. jejuni infection will develop GBS, but in patients with the 
O19 strain, the rate increases to 1 out of every 158 [9]. 
2.4 Immune Response/Immunity 
 The self-limiting nature of the clinical disease course in most campylobacteriosis 
patients indicates that in individuals with a healthy immune system there is an effective 
immune response defense mechanism to clear the infection.  Further evidence of this is 
supported by studies involving HIV-infected patients who have a defective cellular 
immune response.  Immuno-defficient patients experience more severe symptoms, a 
higher frequency of relapses and may suffer from bacteremia from C. jejuni because their 
immune system is unable to clear the bacteria when it reaches the bloodstream[98].   
 Black et al[76] studied experimentally infected humans, and reported that 
infection may provide some protection against future infections. Seventy-two adult 
volunteers ingested various doses of C. jejuni strain A3249; 75% became infected and 
18% were symptomatic.  One month later two volunteers, who were previously infected 
and experienced symptoms, were re-challenged along with five new volunteers.  Neither 
of the re-challenged volunteers became infected while all five new volunteers did 
(P=0.048).  Another group of 39 adult volunteers were given varying doses of C. jejuni 
strain 81-176; 100% of these volunteers became infected (all had positive stool cultures) 
and 46% were symptomatic.  Seven members of the 81-176 strain group were re-
challenged a month later along with twelve new volunteers. None of the re-challenged 
volunteers developed diarrheal illness while 6 of the 12 new volunteers did (P=0.034).  In 
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both experiments patients were re-challenged with the same strain of C. jejuni showing 
that infection can provide short-term homologous immunity. 
 The exact mechanisms of the host recognition of the bacteria and immune 
response are unclear.  Both an innate and adaptive immune response are involved in the 
response to invasion and colonization by C. jejuni and C. coli[99].  The innate immune 
response is also called non-specific or broad-specific immune response since the cells 
that are part of the response do not recognize a specific invading pathogen; rather they 
recognize all foreign cells and acts as soon as the foreign cells are recognized.  The innate 
immune response also initiates the adaptive immune response which has cells that are 
designed to recognize a specific foreign cell but requires a lag time for antibodies to be 
produced.  
2.4.1 Innate Immune Response 
 Recent studies have indicated that structural components of the bacteria and 
proteins synthesized by C. jejuni during invasion and adhesion elicit an innate immune 
response from the intestinal epithelial cells[100].  A study at the Naval Medical Research 
Center in Maryland suggested that C. jejuni can induce the release of interleukin-8 (IL-8) 
by two mechanisms.  One requires adhesion to the epithelial cell wall and/or invasion 
into the cell and the other is activated by surface proteins on the cytolethal distending 
toxin (CDT)[101].  IL-8 is an inflammatory chemokine that attracts neutrophils to the site 
of the infection, where the responding neutrophils are able to phagocytose the invading 
bacteria and clear it from the cell.  Another study at the University of Nottingham in the 
United Kingdom found that C. jejuni was a transcriptional activator of NF-κB (nuclear 
factor-kappa B)[102].  NF-κB functions as part of the innate immune response by 
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stimulating the transcription of the genes for cytokines and chemokines[103]. The 
resulting secretion of cytokines/chemokines and other mediators leads to the activation of 
macrophages and the recruitment of polymorphonuclear leukocytes in the inflammatory 
response.  Macrophages ingest and phagocytose invading cells.  Macrophages also play a 
role in the adaptive immune response by acting as antigen presenting cells in the creation 
of antibodies.  In in-vitro experiments, when human T84 epithelial colon cells were 
cultured with C. jejuni, the epithelial cells up regulated the expression of dendritic cell 
and T-cell chemoattractants[104].  These chemoattractants bring T-cells to the site of the 
infection.  The T-cell and mature dendritic cells then act as antigen presenting cells and 
activate the adaptive immune response[105, 106].   
2.4.2 Adaptive Immune Response 
 The adaptive immune system produces an antibody response that is specific to 
Campylobacter infections.  Antibody production is a delayed response.  The initial 
specific antibodies, immunoglobulin M (IgM) are produced by the 8th day post infection, 
and IgG first appear around 10 days after the first symptoms, while IgA peaks about 2 
weeks post onset of symptoms[107].  Although IgM is short lived and IgA disappears 
after 5 weeks,  IgG has been detected in the sera of infected individuals up to a year post 
infection[108].  A study of workers in a poultry processing facility found that long-term 
workers (working for > 1 month) had significantly higher anti-Campylobacter IgG 
concentrations than the short-term workers.  There was no significant difference detected 
in the levels of IgA[109].  This indicates that the long-term workers have been exposed in 
the past, and have circulating IgG from past exposures that the short-term workers have 
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not developed yet.  Current exposure is the same for both long- and short-term workers so 
no IgA differences are observed.   
 Studies of populations in hyper-exposed regions of the developing world have 
shown that in young children, an increase in age correlates with a decrease in the illness 
to infection ratio[110].  In these populations children develop a resistance to colonization 
between 2-5 years old.  The convalescent excretion period is shortened with age due to a 
gradual increase in Campylobacter-specific circulating antibodies as the child ages[111].    
A study of children in Bangladesh found that levels of IgA continued to increase 
throughout childhood, while IgG peaked between 2-4 years old and IgM reached a 
plateau at the same age[112].   
 Further evidence of the immunity provided by IgA was studied in a population of 
infants in Mexico.  The attack rate for diarrhea caused by C. jejuni was significantly 
higher (p <0.0005) in the group of infants that were not breast fed compared with the 
infants that were breast fed.  The human breast milk of the infants who were fed breast 
milk fed infants and who developed diarrhea did not contain anti-Campylobacter specific 
IgA[113].  Babies that are breast fed receive milk that has the same antibodies as their 
mother.  Thus in the group of infants who were breast fed but still developed diarrhea, the 
mother did not have the antibody to pass on to her baby.   
 A study of IgA in adults was carried out amongst United States military personnel 
participating in military exercises in Thailand.  Personnel who had a pre-travel anti-C. 
jeuni antigen IgA titer less than 450 were 1.6 times as likely (P=0.05) to have 
campylobacteriosis associated diarrhea during their stay in Thailand than the personnel 
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who had a pre-travel titer greater than 450[114].   This indicates that high levels of IgA 
may provide short-term immunity against future infection. 
2.5 Diagnosis 
 The original isolation of Campylobacters from stool was achieved in 1968 
through the use of membrane filtration and culture.  Campylobacters are able to pass 
through a filter membrane, due to their smaller size, while other bacteria that may be 
present in the stool sample cannot not[115].  In 1977 Martin Skirrow developed a 
selective media, for the culture of Campylobacter, containing vancomycin, polymyxin B, 
and trimethoprim in a blood agar base with lysed horse blood[2].  Since the development 
of Skirrow’s culture media, several variants have been developed depending on the type 
of sample (fecal, environmental or water) in order to obtain more growth quicker, 
eliminate other competing bacteria and make the media cheaper to prepare[116-119]. 
Culture remains the gold standard for clinical diagnosis, although the media used may 
differ from laboratory to laboratory.  Some laboratories have started to again use 
membrane filtration and a less selective media in order to culture C. upsaliensis[120], 
which cannot grow on the standard culture media.   
 The antimicrobial agents in the standard selective culture media (Skirrow’s or 
similar media) are inhibitory to C. upsaliensis and some strains of C. jejuni and C. coli.  
Since their growth is normally inhibited in most diagnostic laboratories, the incidence of 
C. upsaliensis, which also causes enteric infection, is underreported.  Another drawback 
of the standard culture method is the long incubation time (48 hours) required to grow an 
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isolate.  Once Campylobacter colonies have formed on the culture plate, phenotypic tests 
are required to confirm the isolate and determine the species.  These tests include the 
morphology, motility, catalase, oxidase, hippuricate hydrolysis test, indoxyl acetate 
hydrolysis, production of hydrogen sulfide (H2S) and the antibiotic sensitivity to 
cephalothin and nalidixic acid.  One problem with the phenotypic tests that are designed 
to differentiate between the species is that not all strains within a species behave the same 
for each test; 5-8% of C. jejuni isolates do not express hippuricase activity which has 
been considered a hallmark of C. jejuni colonies[11]. 
 Dark-field microscopy as a method of rapid diagnosis of campylobacteriosis was 
proposed in Colorado in 1982[121].  Dark-field microscopy involves examination of the 
stool sample for the presence of organisms with the typical darting or corkscrew motion 
of Campylobacter spp., and the presence of leukocytes or erythrocytes.  While this test 
can be performed quickly, its sensitivity is only 36% and this falls to 28% if the stool 
samples are viewed more than two hours post collection[121].  This decline in sensitivity 
could be due to a lack of motility, due to death of the organism.  While the specificity 
was 99%, the overall positive predictive value (probability, given a positive test that a 
patient has the disease tested for) of this method of diagnosis was only 62%. 
 Due to the above indicated drawbacks with the culture method for diagnosis of 
Campylobacter enteritis there has been considerable work to look for a new diagnostic 
method.  A Latex agglutination test has been developed to help confirm and identify the 
species in place of the phenotypic tests, but an evaluation of the test found it lacked the 
ability to differentiate between C. jejuni/C. coli and C. upsaliensis or C. lari[122].  The 
analysis of this test found that the sensitivity was 100% for C. jejuni or C. coli isolates, 
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but only 87% if all isolates tested are included and only 14% of Campylobacter isolates 
other than C. jejuni and C. coli.  The specificity was reported at 100% of the 101 non-
Campylobacter organisms that were tested[122].   
 An enzyme-linked immunosorbent assay (ProSpecT Microplate assay; Alexon-
Trend, USA) is on the market for the rapid detection of C. jejuni and C. coli from fecal 
samples.  This test has been evaluated on multiple occasions and the sensitivity has been 
reported at 96, 89.1 and 80%, while the specificity was reported at 99, 97.7 and 
100%[123-125].  Tests using PCR to detect Campylobacters directly from human fecal 
samples have been developed, but due to the materials and labor required, are currently 
only used in the research setting[77].   
2.6 Treatment 
 The majority of symptomatic Campylobacter infections are acute and self-
limiting, as such most patients do not need antimicrobial therapy and only require oral 
replacement of fluids and electrolytes[82].  However, severely ill patients may need to be 
admitted to a hospital for parenteral fluid replacement and antimicrobial treatment in 
addition to oral re-hydration therapy.  The antibiotics normally recommended to treat 
human campylobacteriosis are fluoroquinolones (ciprofloxacin and levofloxacin are the 
most common) and macrolides (erythromycin, azithromycin and clarithromycin).  Some 
fluoroquinolones (enrofloxacin and sarofloxacin) have been used in the past for the 
prophylactic treatment of poultry. 
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 Antibiotics may be warranted in patients that have a bloody stool, high fever, 
prolonged illness (defined as symptoms lasting longer than 1 week), pregnancy, and 
when there is coinfection with HIV or AIDS or other immunosuppressant conditions.  In 
these situations erythromycin and azithromycin are the current drugs of choice[126-129].  
While there is a small amount of resistance developing to erythromycin, it remains the 
drug of choice recommended by the CDC.  Antibiotic therapy should only be used when 
necessary in order to limit further emergence of resistance to potentially life saving drugs.  
Since resistance rates vary by country and class of antibiotic, clinicians should consider 
where the infection originated when choosing antibiotic therapy[130, 131].  
 Erythromycin is the more cost effective macrolide when compared to 
azithromycin (the newer macrolide), yet both are equally as effective. C. coli has shown 
high levels of resistance to erythromycin.  However, the incidence of infection by C. coli 
remains low in the United States so macrolides are still recommended for treatment of 
campylobacteriosis. Ciprofloxacin[132] and Norfloxacin[133] have been shown to be 
successful in reducing the duration of symptoms but an increasing prevalence of 
fluoroquinolone resistance has emerged so continued use of fluoroquinolones to treat 
campylobacteriosis is cautioned. 
 The empiric treatment of enteric infections is controversial due to the emergence 
of antibiotic resistance, and the possibility of treatment failure and relapse or future 
resistance to all antibiotics.  Children who are treated empirically with antibiotics before 
the etiologic agent is determined, may be at a higher risk of hemolytic uremic syndrome 
if the agent of infection was E. coli O157:H7 (a more frequent cause of bloody 
diarrhea[134]), not Campylobacter spp.[135].  Clinicians, in some cases, will not 
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establish the etiologic agent responsible for an enteric infection before starting antibiotic 
treatment; therefore it is important to consider the possibility of antibiotic resistance and 
related complications when selecting antibiotic therapy.  One study found that the 
usefulness of antibiotic therapy decreased dramatically if it was not administered early in 
the infection[86].  Although, the majority of campylobacteriosis infections are relatively 
mild and therefore do not require antimicrobial therapy, severe cases require antibiotic 
treatment, early in the clinical course, if possible.  In such cases it may be important to 
perform antibiotic susceptibility test to ensure appropriate choice of medications.      
2.7 Antibiotic Resistance 
2.7.1 Prevalence 
 In recent years the resistance to fluoroquinolones has rapidly increased 
worldwide[136], and resistance to macrolides is on the rise in some areas[137].  
Worldwide the prevalence of antibiotic resistance varies depending on the species of 
Campylobacter concerned and the class of antibiotic in question.  In Ireland, dramatic 
increases were observed in the prevalence of resistance between 1996/1998 and 2000.  
They tested a collection of C. jejuni and C. coli and found that while resistance to 
erythromycin had remained constant at 2%, resistance to tetracycline increased from 14% 
to 31%, and resistance to ciprofloxacin had increased from 0% to 30%[138].  In separate 
susceptibility tests of  C. coli isolates in Germany and Spain, 29.4%[139] and 
34.5%[140], respectively, were resistant to erythromycin.  None of the German isolates 
and only 3.2% of the Spanish C. jejuni isolates were resistant to erythromycin.  The 
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observed prevalence estimates of resistance to ciprofloxacin was 45.1% in Germany[141] 
and 72% in Spain[140], greater than the percentages of resistance in Ireland. 
 In developing countries antibiotics are often sold unrestricted which can lead to 
improper usage in humans and animals[142].  In Thailand Campylobacter spp. resistance 
to ciprofloxacin was 84% in 1994.  In a study of mixed isolates from children in Lagos, 
Nigeria, 79.8% were resistant to erythromycin[143]. 
 In the United States, the prevalence of resistant strains is not as high as other parts 
of the world, but it is on the rise.  In Minnesota, the prevalence of resistance to 
ciprofloxacin was only 1.3% in 1992 and but had increased to 10.2% by 1998[144].  Due 
to this increasing trend of antibiotic resistance, the National Antimicrobial Resistance 
Monitoring System for enteric bacteria (NARMS) was established in 1996.  NARMS was 
established as a collaborative effort between the Food and Drug Administration's Center 
for Veterinary Medicine (FDA CVM), U.S. Department of Agriculture (USDA), and the 
Centers for Disease Control and Prevention (CDC)[145]. The goals of NARMS are to 
provide data on the extent and trends of antimicrobial drug susceptibility and resistance 
for enteric bacterial organisms and to inform physicians and veterinarians of the patterns 
they observe.  A total of 297 isolates were tested in 1990 by the Centers for Disease 
Control (CDC), prior to the creation of NARMS, and no ciprofloxacin resistance was 
detected.   However, the percentage of resistance had increased to 13% of 217 isolates 
tested by NARMS in 1997 and 19% of 384 isolates in 2001[146].  Resistance to 
erythromycin is variable between C. jejuni and C. coli at 1-5% and 5-9% of  isolates, 
respectively[137].  
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2.7.2 Complications of Antibiotic Resistance 
 Several studies have shown that patients with a quinolone resistant strain of C. 
jejuni experience a longer duration of illness than those with a quinolone sensitive 
strain[147].  In Minnesota, patients who were treated with fluoroquinolones and were 
infected with a fluoroquinolone resistant strain had a median duration of diarrhea of 10 
days while those who were infected with a fluoroquinolone sensitive strain had a median 
duration of diarrhea of only 7 days (p=0.03)[144].  FoodNet data collected in 1998-1999 
showed that patients who took no antidiarrheal medication and were infected with 
ciprofloxacin resistant strain had a mean duration of diarrhea of 9 days while those who 
were infected with a ciprofloxacin sensitive strain only experienced 7 days of diarrhea 
(p=0.04)[148].  The same was shown by a study in Denmark in 2001-2002 where patients 
with a fluoroquinolone resistant strain had a mean duration of illness of 13.2 compared 
with 10.3 days of the sensitive strain patients(p=0.001)[147]. 
2.7.3 Controversy with Antibiotic Usage in the Poultry Industry 
 The rise of fluoroquinolone resistance appears to coincide with the widespread 
use of related fluoroquinolones in large scale food animal production, especially poultry 
production.  This is important since raw and undercooked chicken is considered a major 
risk factor for C. jejuni infection.  Two fluoroquinolones, sarafloxacin and enrofloxacin, 
were licensed for use in US poultry in 1995 and 1996 respectively, and by 1997 13% of 
217 human isolates submitted to NARMS were resistant to fluoroquinolones when no 
fluoroquinolone resistance had been detected in prior years[146].  Due to this apparent 
link Abbott Laboratories withdrew sarafloxacin from use in poultry in 2000 and the FDA 
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withdrew enrofloxacin from the market for poultry in 2005 (after Bayer Corporation 
disputed the link for 4 years[149]).  In the United Kingdom, a survey of retail chickens 
prior to the licensure of enrofloxacin for use in poultry production in the UK, found only 
3% of Campylobacter isolates from domestically raised chickens were resistant to 
ciprofloxacin[150].  This study also tested chickens imported from mainland Europe, 
including some chickens from France where enrofloxacin was licensed for use at the time 
of the study.   Of the imported chickens, 27% of the Campylobacter isolates were 
resistant to ciprofloxacin.  More evidence supporting the theory that the increase in 
Campylobacter strains resistant to fluoroquinolones is linked with the use of 
fluoroquinolones in poultry production is provided by a study conducted in Denmark.  
Fluoroquinolones are not used in Danish poultry productions and the percentage of 
human Campylobacter isolates that are fluoroquinolone resistant is only 6.5% for 
infection acquired in Denmark compared to 67.4% of those infections acquired abroad 
(including neighboring countries where antibiotics are used in poultry production).  Due 
to the high incidence of campylobacteriosis worldwide, it is important to limit the level of 
antibiotics being used in poultry production due to the ability of bacteria to become 
resistant through transfer from other commensal bacteria.  If in the future, more strains 
become resistant to more and/or different classes of antibiotics, the duration of illness 
experienced by patients may be longer, and symptoms may be more severe.  
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2.8 Pathogenesis 
 The pathogenic mechanism of C. jejuni has been debated and is still not 
completely clear, one researcher called the mechanism “sketchy”[151].    Some of the 
debate may be due the high degree of genetic and phenotypic diversity amongst C. jejuni 
strains resulting in widely varying experimental results depending on the strain used.    In 
general, Campylobacters enter the host intestine by passing through the stomach acid 
barrier and colonize the distal ileum and colon.  In order to colonize and cause disease, C. 
jejuni uses a variety of mechanisms including bacterial cell motility and chemotaxis, 
adhesion, invasion and cytotoxin as well as enterotoxin production[152].   
 Campylobacters are motile through the use of their uni-polar or bi-polar flagella.  
The direction of their motion is driven by chemotaxis, which was first described in 1883 
by Theodor Engelmann and in 1884 by Wilhelm Pfeffer[153-156].  Chemotaxis is 
described as the movement of bacteria toward certain stimuli and away from others.  C. 
jejuni exhibits positive chemotactic behavior (movement towards) for L-fucose[157] 
which is the terminal sugar in mucin, but it is repelled from bile components.  Further 
research has shown that amino acids L-aspartate, L-cysteine, L-glutamate, and L-serine, 
and the organic acids pyruvate, succinate, fumarate, citrate, malate, and a-ketoglutarate 
are all positive chemoattractants for C. jejuni[158].  All of the identified chemoattractants 
are chemicals or compounds that are found in or near the mucosa of the epithelial lining 
of the intestine, thus directing the bacteria towards its invasion target, the epithelial cells 
of the colon and closer to the wall of the intestine to avoid being cleared by fluid flow.  
Once a chemoattracting molecule is bound to a receptor on the bacteria, 
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autophosphorylation of the Che proteins conveys the signal through signal 
transduction[159, 160].  This same mechanism works to drive the bacteria away from 
chemorepellents.  The signal can be to change directions and or speed.  C. jejuni has 
shown the ability to move at higher velocities in more viscous environments due to its 
shape and flagellar activity[161].  The flagella has been shown to be necessary to 
overcome peristalsis and for entry into the mucous layer of the intestine[162] which 
allows the bacteria to cause disease. 
 Adhesion of the bacteria to epithelial cells on the wall of the intestine has been 
shown not to be essential for the colonization of the intestine, but it does facilitate cell 
invasion[163].  C. jejuni can adhere to the epithelial cells by a variety of bindings; these 
include polyoma enhancer binding factor 1, PEB1 (a homolog of Gram-negative ABC 
transport systems)[164], Campylobacter adhesion to Fibronectin ,CadF (a fibronectin 
binding protein)[165], a major outer membrane protein[166], lipooligosccharide[167] and 
a novel surface-exposed lipoprotein specific to C. jejuni[168].  The ability to adhere to 
the cell allows the bacteria to invade the intestinal lining. 
 Host cell invasion has been observed in experimentally infected infant macaque 
monkeys[169] and swine primary intestinal cells[170], but no consensus has been 
reached as to the mechanism or pathway[171].  The damage caused by toxins released 
intracellularly and extracellularly can cause epithelial cell death.  The cytotoxin, 
cytolethal distending toxin (CDT), is a tripartite toxin of the AB toxin type; two parts, 
CdtA and CdtC, form the binding components, while the third part, CdtB, is the active 
subunit[151].  Once in the cell, CdtB is transported to the nucleus and arrests the cell in 
the G2 phase of the cell cycle by causing double strand breaks in the DNA[172].  
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Previous studies reported the cell cycle arrest was due to chromatin disruption[173].  This 
cell arrest leads to apoptosis.  Both the toxins and dead cells stimulate inflammation and 
further epithelial damage leading to a loss of function of the intestinal mucosa.  The toxin 
alters the absorptive capacity of the epithelial cells, which causes water to rush out of the 
cells resulting in watery diarrhea.  Also as mucosal cells are damaged and die, they are no 
longer able to carry out their normal absorption of fluid from the intestinal tract, resulting 
in more fluid being passed in the stool and diarrhea[174].  In some cases, C. jejuni may 
invade the sub-mucosa.  When the cells from the sub-mucosa die and fall off, a pore is 
opened that allows blood to enter the intestinal lumen resulting in bloody diarrhea.  
Mucus may also be found in the stool due to loss of adhesion of the mucosal layer from 
the damaged epithelium and due to the irritation of the mucin producing cells.  
 In response to the invasion, host cells release interleukin-8 (IL-8)[175] and 
leukotrine B4 (LTB4)[176] which cause the recruitment of more polymorphonuclear 
leukocytes and macrophages to the area.  These inflammatory cytokines can cause fever 
in the host by acting as pyrogens and increasing the set point of the hypothalamic 
thermoregulatory center.  The abdominal pain that is experienced by some patients may 
be caused by the inflammatory response as well.  The inflammatory response elicited by 
the lipopolysaccharide interacts with signaling molecules that act on the enteric neurons 
to cause abdominal pain or cramps[177].  The distention and irritation caused by the 
inflammation of the small intestine and colon may cause vomiting as a result of the 
stimulation of the visceral afferent neurons[178].  Excessive distention or irritation of the 
duodenum provides the strongest stimulus for vomiting; impulses are transmitted by 
vagal and sympathetic afferents to the bilateral vomiting center of the medulla[179].  The 
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motor reactions are then initiated to cause vomiting.  Nausea is the conscious recognition 
of the subconscious excitation in area of the medulla closely associated the vomiting 
center.   
 In most cases C. jejuni is sensitive to complement-mediated lysis and are killed 
rapidly in the blood stream even in the absence of specific antibodies[180].  However, 
there are some strains that are highly resistant to serum[181] and can colonize the blood 
stream or survive for up to seven days in monocytes[182].  The ability to “hide” in 
monocytes can result in long-term bacteremia in the host.  This bacteremia can lead to 
further complications such as meningitis or abortion if fetal infection occurs[183]. 
 When specific serotypes (O:19 and O:41) of  C. jejuni are present in the blood 
stream, the lipooligosaccharide structures on the surface of the bacteria can molecularly 
mimic peripheral nerve gangliosides[184].  This mimicry results in the generation of 
autoreactive antibodies that cause nerve inflammation and tissue damage[185].  This 
damage is the start of Guillain-Barré syndrome (GBS).  One theory on GBS initiation is 
that anti-self antibodies specific for the ganglioside to bind to the surface of Schwann 
cells and this starts the disease progression[186].  That binding may activate complement 
which forms transmembrane pores resulting in the tissue damage and loss of neural 
activity[187]. 
2.9 Pathogenicity/Virulence  
 Campylobacter spp. must be able to colonize the intestine of the host in order to 
cause disease.  Therefore any mechanism that makes colonization easier may increase the 
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pathogenicity of the organism.  Pathogenicity and virulence of Campylobacter are 
influenced by certain genes.  For instance, research has evaluated how the loss of 
function of certain genes affects the ability of C. jejuni to infect the host.  The spiral 
shape and flagellum of the individual bacteria enhance bacterial motility in viscous media 
such as the surface layer of the intestinal mucus.  Removal of the flagella function 
through the creation of a mutation in the flaA gene resulted in decreased ability of C. 
jejuni to colonize the gut of chickens[188].  Campylobacters use chemotaxis to help 
control and direct motility.  By creating a mutation in the chemotaxis regulator gene cheY 
researchers were able to reduce the number of symptomatic ferrets compared with the 
wild type[189].  That mutation made the bacteria unable to respond to signals from the 
host environment.  The CadF protein is an outer membrane protein that facilitates the 
binding of C. jejuni to fibronectin.  The disruption of the gene cadF results in the 
inability of that strain to colonize the cecum of day old chicks[190].  Another protein that 
plays a role in the adhesion of C. jejuni to the intestinal lining is PEB1 also known as cell 
binding factor 1, CFB1.  Disruption of peb1A gene caused significant loss in invasion and 
adherence ability in cell culture and a significant decrease in the symptoms of mice 
challenged with the mutant strain[191]. 
 The cytolethal distending toxin (CDT) causes progressive cell distention and cell 
death in cell culture experiments[192].  The genes cdt A, cdtB, and cdtC code for 3 
proteins that combine to make a holotoxin that causes the cytolethal effect of arresting 
cells in the G2 phase of their cell cycle[193].  These three genes have been found in 
almost all strains of C. jejuni, and C. coli as well as strains of C. fetus and C. 
upsaliensis[110], but the gene expression levels varies between strains of C. jejuni and 
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between species.  C. coli has lower expression levels which could explain why the 
clinical course of enteritis due to C. coli appears to be milder[194].  Some strains have a 
higher expression of the cdtABC genes, like the well characterized C. jejuni 81-176, 
which appears to cause more severe disease. It has been hypothesized that the CDT has a 
negative effect on the net absorptive ability of the intestinal epithelium through inducing 
cell death and it affects the replication in active secretory immature enterocytes[110]. 
2.10 Epidemiology 
2.10.1 Risk Factors 
 Most cases of campylobacteriosis are considered sporadic (they are not associated 
with an identifiable outbreak of cases) as such determining the source of infection is 
difficult.  Therefore, there is substantial need to determine key risk factors for infection, 
among sporadic cases, in order to help prevent future illnesses.  Several risk factors have 
been identified through case-control studies: poultry consumption, international travel, 
drinking untreated water or unpasteurized milk, contact with animals or contact with 
people who are similarly infected.  
2.10.1.1 Consumption of Contaminated Food or Water 
 The most commonly identified risk factor is poultry consumption.  Although each 
case-control study varied slightly in the questions about the specific type of poultry or 
where the poultry  was consumed, 19 out of 24 case-control studies identified poultry 
consumption as a risk factor for campylobacteriosis[11].  In a 1997 Danish study, they 
separated poultry into 24 different categories, including popular brands and packaging 
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types, the only poultry exposure that was significantly associated with 
campylobacteriosis was undercooked poultry (all-types)[13].  Undercooked chicken was 
also found to be a significant risk factor for disease in the Denver and Fort Collins, 
Colorado area in 1981[195], in the population older than 5 in Australia in 2002[196], in 
the Eastern Townships of Québec in 2001[197], and in FoodNet sites in the United States 
in 1999[198].  The FoodNet study reported the largest population attributable fraction 
(24%) associated with the consumption of chicken in a restaurant.  The association with 
the consumption of chicken in restaurants, without differentiating if the meat was 
undercooked, was also identified in New Zealand in 1995[199], and in Hawaii in 
1998[200].    
 Other evidence supporting poultry as a risk factor for Campylobacter infection is 
provided by a study in Belgium in 1999 when all poultry meat and eggs were removed 
from the market due to contamination with dioxins.  This resulted in a 40% reduction in 
the observed number of cases based on the expected number of cases of 
campylobacteriosis based on the predicted model from the previous years.   The case 
counts returned to the predicted values after poultry products were re-introduced to the 
market[201].  A study in Norway found that eating poultry produced in Denmark or 
Sweden was strongly associated with human infection while the consumption of poultry 
produced in Norway was not[202].  The authors associated this with the low prevalence 
of Campylobacter infection in the poultry flocks of Norway. 
 Drinking untreated water has been associated with outbreaks of 
campylobacteriosis, and has been identified as a risk factor for infection in case-control 
studies.  A study in Colorado in 1981 found that cases were more likely than controls to 
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report having drunk “raw” (untreated) water from a stream, river or lake, OR=10.74[195].  
Similar associations were found in England in 1991[203] and Sweden in 2002[204].  The 
Swedish study also found that having a well as the household water source was 
significantly associated with developing campylobacteriosis.  Two studies in New 
Zealand found non-urban household water sources [205] or rainwater as the water source 
[199] to be associated with increased risk of disease.  In Canada, an outbreak of 
gastroenteritis caused by both Campylobacter spp. and E. coli O157:H7 was attributed to 
cattle manure entering the municipal water supply following heavy rains[206]. A study 
conducted in Finland in 2002 found that swimming in a natural body of water was a 
significant risk factor for campylobacteriosis[207]. 
 Other risk factors that have been identified are unpasteurized milk [13, 195, 197, 
204, 208], anti-secretory drugs or consumption of milk from bottles that had lids that had 
been attacked by birds[12], consumption of offal[196], sausages at a barbeque[202], red 
meat at a barbeque [13], pork[13, 208], and grapes[13]. 
2.10.1.2 Animal Exposure 
 Animal exposure is another commonly reported risk factor.  The species and age 
of animal implicated varies from study to study. A study of infants in the United States 
found that having any kind of pet with diarrhea in the household was associated with 
increased risk of campylobacteriosis[14]. Another study of young children less than 6 
years of age in Sweden in 2002 found that having a dog of any age in the household was 
a significant risk factor (OR=8.4)[204] as did a Norwegian study in 1992 
(OR=5.04)[202].  The US FoodNet study in 2004 found an association between all ages 
of campylobacteriosis patients and puppies (OR=3.2)[198].  The Nottingham Health 
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Region study of 1995 also implicated puppies as a source of infection[12].  Similar 
associations with young dogs less than 6 months of age were found in an Australian study 
of the population older than 5[196] and in one study of children less than 35 months of 
age[209].  Cats or kittens were identified as risk factors in Colorado in 1981[195] and 
Denmark in 1997[13].  Other animals that have been implicated as risk factors for 
campylobacteriosis are chickens [13, 196, 208, 209], and cattle[199], [13]. 
  Pets as a risk factor is supported by numerous cross sectional studies conducted 
mainly in Europe that have shown that the prevalence of Campylobacter infections in 
dogs ranges from 5% to 70%[34, 210-213] depending on the test used for diagnosis of 
campylobacter and the living conditions of the dogs sampled.  Dogs and cats show a high 
prevalence of infection with C. upsaliensis[37], which can infect humans; however, it is 
not regularly identified using standard diagnostic tests in the United States due to 
inhibitory effects of the routine culture media[41].  When Campylobacter infection of pet 
animals is limited to just C. jejuni, the prevalence ranges from 3% to 22%[37, 213, 214], 
depending on the living conditions of the sampled animals.  Although the prevalence of 
C. jejuni in pet animals may be considered low, it is an important public health concern 
since both healthy pets and those with diarrhea have been reported to have a similar 
prevalence of infection[35] with equal possibilities of shedding bacteria in feces.  
However, one study found a significant difference in the prevalence of infection between 
healthy young (less than 1 year) dogs and diarrheic dogs of the same age[215]. These 
results suggest that apparently healthy animals may just as likely to be infected with 
campylobacter as sick animals, depending on the age of the animal, and these animals can 
act as potential sources of infection to humans.   Moreover, healthy carrier pet animals 
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may shed the bacteria for up to several months which could be a source of recurrent 
infection in a household. 
 Workers in the poultry industry are at a high occupational risk for Campylobacter 
infections.  One study of a factory in Northern Ireland found that poultry factory workers 
were 3 times more likely to develop campylobacteriosis than the population of the 
surrounding community (p = 0.016)[216].  At a poultry processing plant in Sweden, an 
outbreak of campylobacteriosis occurred when the normal and experienced workers went 
on holiday and were replaced with inexperienced teenagers[217].  Only 29% of the 
experienced staff became sick during this outbreak, while 71% of the replacement 
workers did, since the replacement works did not have immunity from previous exposure.  
A case-control study in Michigan found that those who practiced poultry husbandry had 
increased odds of campylobacteriosis compared to those who did not (OR = 6.884; 95% 
CI = 1.438 - 32.954).  The same study estimated that 18% (95% CI = 6% - 30%) of cases 
of human campylobacteriosis that occur in rural populations are attributable to poultry 
contact[218]. 
2.10.1.3 Other Risk Factors  
 Another risk factor that has consistently been identified in case-control and 
descriptive studies of campylobacteriosis is international travel.  In the FoodNet study in 
1999, 13% of the cases interviewed reported international travel 7 days prior to the 
development of symptoms, compared to only 1.5% of the controls, for an odds ratio 
(OR=10.0)[198].  Travel abroad was also identified as a risk factor in Switzerland in 
1991 with an OR of 21.2[219], in Denmark in 1997[13], and the Nottingham Health 
Region in England in 1995[12].   Campylobacter spp. is frequently identified as the 
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etiologic agent responsible for traveler’s diarrhea, adding to the implication of 
international travel as a risk factor for campylobacteriosis[220, 221].  Other studies have 
also identified antibiotic use[200], and diabetes[12] as risk factors for disease.  It has 
been hypothesized that antibiotics may provide a selective advantage to drug-resistant 
bacteria by lowering the infectious dose required to produce disease, or that previous 
antibiotic use may result in decreased colonic bacterial flora so there is less resistance to 
colonization by Campylobacter spp[222, 223].  
 While person-to-person transmission is believed to occur, contact with someone 
with similar symptoms has not been documented as a risk factor in Campylobacter case-
control studies.  Person-to-person transmission, however, has been documented among 
family members [224]  Childcare centers are prime locations for Campylobacter spp. to 
be spread due to large numbers of children present and the decreased hygiene practices of 
children in that age.  In Brussels in 1991-1992 an outbreak of C. upsaliensis affected 44 
children at 4 related child care centers[225].  Restriction fragment length polymorphism 
(RFLP) showed that there were two clonal variants circulating, one variant affecting one 
center and the other affecting the other three centers.  In a case-control study of childhood 
diarrhea of all causes in Sao Paulo, Brazil “not sending a child to a daycare center” 
(childcare in the home) was found to be protective against diarrhea (OR= 0.58, P = 
.004)[226]. 
2.10.2  Incidence 
 In descriptive studies of enteric illnesses in developed countries, infections by 
Campylobacter spp. are among the most common.  In Australia, Campylobacter 
infections are the leading causes of gastrointestinal illnesses among all the notifiable 
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enteric pathogens[17].  Campylobacter is the most common bacterial cause of diarrhea in 
England and Wales[16] and in the United States, it is reported more frequently than any 
other bacterial pathogen[3].   
 The incidence of disease varies widely worldwide, the highest reported incidence 
occurs in the South Pacific.  In New Zealand, the incidence of campylobacteriosis has 
been reported at 300-396 per 100,000[18, 19] and in Australia the incidence was reported 
at 116.5 per 100,000 in 2003[17].  The reported incidence risk (per 100,000) is slightly 
lower in Europe at 95 in Switzerland[213], 82 in Denmark in 2001[227], and 66.65 in 
2006 in Sweden[228].  The average incidence risk among sites participating in the 
FoodNet program in the United States was 12.71 per 100,000 in 2006 and the reported 
state incidence in Tennessee was 7.4 per 100,000[20].  While the reported incidence in 
the US is lower than other parts of the developed world, it still represents an important 
health issue, it has been estimated that the true incidence of campylobacteriosis in the US 
is 800 per 100,000 population[3].  Differences in health care systems may influence the 
reported incidence of campylobacteriosis.   In countries where there is a higher 
percentage of insured individuals, either by government universal healthcare or private 
health insurance, these individuals will be more likely to visit the doctor when they are ill 
compared to individuals who don’t have health insurance.  In the United States it has 
been reported that 16% of the populations does not have any form of health 
insurance[229].  While countries like Canada have government health insurance plans 
that are designed to ensure that all residents have access to health insurance.  In these 
countries, more cases will be reported since more individuals will visit their doctor and 
are more likely to have their stool cultured.   Due to under-reporting, the real incidence of 
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campylobacteriosis may be closer to 900 cases per 100,000 people in the United States, 
based on an estimate in 1999[3]. 
2.10.2.1 Demographic Distribution 
 All ages can be affected, but there appears to a bimodal age distribution.  The 
highest age-specific incidence occurs in young children[204, 230, 231].  Some reports 
have categorized this incidence as all children under 5 years[4, 204, 231] while others 
have been more specific, limiting the highest incidence to just children under 1 year[230].  
In some studies, a smaller second peak has been documented, this occurs in young adults 
of ages 15-30 years[4, 198, 232].  It has been hypothesized that the reason infants and 
young children have the highest reported incidence, is that the parents of young children 
are more likely to take their child to the doctor than themselves[233].  With more young 
children seeking medical care there is a higher possibility of stool culture and 
documentation by the reporting system[234].  Young children may also have a higher risk 
of exposure due to decreased hygiene from some behavioral patterns, such as crawling on 
the floor and putting objects in their mouths.  Skirrow studied this in 1987, he calculated 
the infection rate based on the total number of samples cultured; the lowest infection rate 
was observed in infants under one year of age, and the highest infection rate was 
observed in the 15-24 age group[235].  It has also been hypothesized that the reason 
young adults (ages 15-30) have a higher reported incidence of campylobacteriosis is that 
this is the age group that does the most international travel[4]. 
 A study of the infectious disease surveillance system in Denmark, of >13000 stool 
samples, found that female patients were more likely than males to be cultured for 
Campylobacter infection (ratio of 1.2:1), although male patients were more likely to be 
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culture positive (RR 1.27,  95% CI 1.21–1.34)[236].  The same study found that the 
oldest age group (60 and older) were the most likely to have their stool cultured, while 
the 15-29 age group was the most likely to be culture positive.  A study in Norway found, 
males were more likely to be infected overall, 57.5% of all campylobacteriosis patients 
were male.  This percentage was even higher (60.3%) in the under 5 year old age 
group[4].  One theory for the higher incidence among males is that males report more 
unsafe food-handling practices and higher consumption of finger foods that are known to 
increase the risk for foodborne diseases[237, 238].  This, however, does not explain the 
sex difference observed in young children where the risks should be similar, due to 
similar hygiene and diet at this age. 
 A descriptive study of FoodNet sites in the United States also found that the 
highest incidence of campylobacteriosis was reported in infants less than 1 year (56.2 per 
100.000) followed by children aged 1-4 years (41.2 per 100,000)[239]. This study also 
reported a smaller peak in the incidence in the population aged 20-29 (30.3 per 100,000).  
As seen in other countries, males had a higher average incidence of infection (24.4 per 
100,000) than females (19.4 per 100,000).  Other studies in the United States have also 
reported a higher percentage of males[195, 198].  A case-control study of the FoodNet 
sites found 54% of cases enrolled in the study were male[198] and a study in Colorado 
found 61.7% of campylobacteriosis patients were male[195].  Both case-control studies 
noted that there was no significant difference in the sex of the patients who participated 
in the study compared to those who didn’t participate in the study.  Overall in the United 
States the highest incidence is observed in the young children, and there is a slight 
predominance of males in most studies. 
 41 
2.10.2.2 Temporal Patterns 
 Worldwide the reported incidence of campylobacteriosis spikes during the 
summer months.  This trend has been noted in both the Northern and Southern 
hemispheres.  In Denmark the highest incidence of disease occurs from July to September 
[236].  In a New Zealand study of recreational water isolates and human disease, the 
authors found the highest concentration of Campylobacters in water samples during the 
summer months, December-February, and also noted a steady increase in incidence of 
human disease from winter through summer[68].  Another study in New Zealand found 
the highest incidence of human disease during summer and noted that this seasonal 
variation was more amplified in the urban areas[240, 241]. 
 In Wales, one study compared the seasonal variation of human Campylobacter 
isolates with that from commercial chicken isolates.  It reported that the number of 
human isolates peaked around weeks 22-25, in early June while the number of chicken 
isolates peaked around weeks 24-26, in late June[242].  This June peak is consistent with 
the data from the FoodNet study in the US that found increasing infection rates during the 
spring and a peak in the rates in June or July[239].  The June/July peak was also 
demonstrated by a study in Massachusetts that compared the incidence of disease with 
the ambient temperature[243].  This study found that the peak in the incidence of 
campylobacteriosis coincided with the peak in the ambient temperature and it occurs on 
average around day 208, in late June.  A similar trend was observed in Michigan, with 
more cases being reported in the summer, especially in rural areas that have a high 
poultry density[232].  
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2.10.2.3 Geographic Distribution 
 The geographic distributions are not as consistent worldwide; some studies have 
reported higher incidence in rural areas while others have reported it in the urban 
areas[232, 239, 244].  A study of the spatial distribution in Manitoba found that the 
incidence was significantly higher in populations living in rural and agricultural areas of 
the province[244].  This study also found that the incidence in young children under 5 
was seven times higher in rural Manitoba compared to the city of Winnipeg.  A study in 
Denmark similarly concluded that living in housing types found in rural areas and living 
in areas with a low population density were associated with an increased risk of 
infection[245]. 
 In the Netherlands, a 2006 study found the highest incidence in the southern 
portion of the country (55.7 per 100,000) compared to the rest of the country (39.1 per 
100,000)[236].  When the country was separated into urban and rural, the higher 
incidence was observed in the urban areas (41.9 per 100,000) compared with the rural 
(32.4 per 100,000).  Similar patterns were observed in New Zealand[246].  In the United 
States, the highest incidence among the FoodNet sites occurs in the California[239].  The 
counties involved in the California site are San Francisco and Alameda counties, both of 
which are very urban.  Contrary to that report, a study in Michigan that classified areas 
into low and high poultry density, found that the higher incidence of campylobacteriosis 
was reported in the more rural areas, which have higher densities of poultry[232]. 
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2.11 Surveillance 
 The overall goal of surveillance is to collect, record, share and analyze data, and 
then disseminate the resulting information to relevant authorities who take action to 
control disease.  The World Health Organization (WHO) has defined four categories of 
surveillance systems for foodborne pathogens: no formal surveillance system, syndromic 
surveillance, laboratory-based surveillance, and integrated food-chain surveillance [247].   
 No formal surveillance system involves investigation of large or unusual 
outbreaks which are performed by outside organizations, such as non-governmental 
organizations (NGOs).  In syndromic surveillance, information is collected on syndromes 
without a laboratory confirmed diagnosis.  Laboratory-based surveillance collects 
laboratory data, and differs from syndromic surveillance because it involves the 
identification of the etiologic agents.  Integrated food-chain surveillance, involves 
collecting data from animals, food and humans in order to provide an overall picture.  
The goal is to track the specific pathogen from animal to human.  The latter three forms 
of surveillance can be either active or passive.   
 The difference between passive and active surveillance is that passive surveillance 
programs wait for the data to be transmitted to the organization while active surveillance 
programs rely on information to be transmitted, but the health organizations also 
regularly contact health care providers or the public to solicit the information actively.  
Active surveillance is more costly but the information is obtained in a more timely 
fashion, the data may be more accurate and complete and active surveillance helps to 
reduce under-reporting.     
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 In passive surveillance, reporting can be voluntary or mandatory, and the agency 
in charge uses routinely collected data. Enter-net is an international passive surveillance 
network for human gastrointestinal infections.  Originally created to monitor Salmonella 
and E. coli in Europe, Enter-net now gathers some information on Campylobacter from 
20 countries in Europe and around the world[248].  The modes of surveillance and 
information provided by each country are varied.  Some countries have mandatory 
reporting but do not seek additional information from patients while the reporting in other 
countries is voluntary or only from certain sentinel sites (smaller sampling sites that are 
approximately representative of the population studied)[248].  These differences in 
surveillance programs make the comparison of the burden of disease for specific 
pathogens across countries and across regions within countries difficult.  One of the goals 
of the network is to develop a consensus on standards for national participation in 
international surveillance.  Global Salm-Surv (GSS), created by the WHO in 2000 for the 
worldwide surveillance of Salmonella, has now started new training programs for the 
worldwide surveillance of Campylobacter[249].  In the United States, passive 
surveillance of Campylobacter infections was implemented in 1982 and 
campylobacteriosis became a notifiable disease.  During this time, isolates were reported 
through the Public Health Laboratory Information System (PHLIS)[7].  Under this 
system, reports of isolates were mailed weekly to the Centers for Disease Control and 
Prevention (CDC) from local health departments.  These reports only included limited 
information since the system did not involve interviewing the patients and cases were not 
actively sought.  Currently, Campylobacter is not on the list of National Notifiable 
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Diseases in the United States[250], but is on the list of notifiable diseases in the state of 
Tennessee[251].  
 In active surveillance, the health officials seek out information instead of waiting 
for it to be reported.  In the United States, the Foodborne Active Surveillance Network 
(FoodNet) is an active surveillance system for all foodborne pathogens, including 
Campylobacter.  It was created in 1995 to gather more complete information on 
foodborne pathogens with the specific goals of determining the burden of foodborne 
disease, monitoring trends in the incidence of disease, attributing the burden of disease to 
specific foods or settings, and to develop and assess interventions designed to reduce the 
burden of disease[252].  Seven states and parts of three other states, participate in this 
network which requires the mandatory reporting of all laboratory confirmed cases.  In 
1999, 11 counties in Tennessee joined FoodNet[253] and the rest followed suit in 
2003[254].  All laboratories in the participating areas, must report any positive laboratory 
results for foodborne diseases to their local health departments.  Depending on the state 
and laboratory, some cultures are sent to the state laboratory for speciation.  The local 
heath department conducts an interview with each patient to collect demographic and risk 
factor information.  The major differences between FoodNet and the previous PHLIS 
system are the follow up on each patient by the health department to collect additional 
information and the requirement that health officials must routinely audit the laboratories 
to ensure that all positive results were indeed forwarded to the health department[255].  
Compiled data is electronically submitted to the state health department and CDC daily.  
The CDC then monitors nationwide spatial and temporal patterns.   
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 One of the major problems with all surveillance schemes, especially passive 
systems, is under-reporting.  In order for a case to be reported the person must go through 
approximately 7 steps (see Figure 2.1)[252].  At each step the percentage of infected 
individuals who continue onto the next steps is diminished. At the bottom of the pyramid 
are all the people who are exposed to Campylobacter, but then the patient must develop 
symptoms, see their doctor, provide a stool sample and have the organism isolated and 
reported.  At each of these steps there are number of factors that might influence whether 
a patient continues onto the next step: health insurance, perceived severity of the 
symptoms, distance to the nearest diagnostic laboratory, fulfillment of stool sample 
request and thoroughness of the laboratory.  In countries where health care is not 
universal, the second step may be the biggest detriment to a case being reported, the 
symptoms must be severe enough for the individual to seek medical care. The factors that 
influence reporting may also explain some of the distributions observed, since parents of 
young children are more likely to take them to the doctor, so children will be most 
represented in the database.  One goal of FoodNet is to reduce the number of patients that 
are lost at each step by actively seeking reports from the laboratories and monitoring the 
reporting process (each event that occurs along the pyramid).  This allows for a more 
accurate and precise estimate of the burden of foodborne disease. In Salmonella it has 
been estimated that for every case that is reported, 38 go unreported[256].  Using some of 
assumptions used to estimate the true incidence of Salmonella and applying similar 
mathmatical equations to the data for Campylobacter, it has been estimated that 
1,400,000 to 2,453,926 cases of campylobacteriosis occur annually in the US[3, 239]. 
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Figure  2.1: Burden of disease pyramid to describe the steps a campylobacteriosis 
patient must go through before the case is reported to the health department 
(Adopted from: Hardnett, F.P., 2004) 
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3.0 Materials and Methods 
3.1 Study Area 
 This study was carried out in sixteen counties in the Eastern portion of the state of 
Tennessee (Figure 3.1, Map A).  The selected counties are served by two health 
departments: the East Tennessee Regional Health Department serves fifteen counties, 
while Knox County maintains it own health department (Figure 3.1, Map B).  The major 
cities in the study region are Knoxville, La Follette, Maryville, Morristown, Oak Ridge, 
Pigeon Forge, and Sevierville.  The Tennessee portion of the Great Smokey Mountains 
National Park and the Big South Fork National River and Recreation Area are also 
located within the boundaries of this area.  Many lakes and rivers are spread throughout 
the area including Watts Bar, Fort Loudon, Chilhowee, Tellico, Douglass, Cherokee and 
Norris Lakes, the Tennessee and Big South Fork Rivers and the Melton Hill Reservoir.  
Numerous recreational activities are available on these bodies of water, which may have 
implications for the transmission of campylobacteriosis. 
3.1.1 Climate 
 The area has a humid subtropical climate that is characterized by hot and humid 
summers and chilly to mild winters.  In Knoxville, the average high/low temperatures are 
88°F/69°F in the summer and 46°F/29°F in the winter, the record high temperature is 
103°F, while the record low is -24°F. In the higher altitudes of the Smokey Mountain 
National Park, average temperatures range from -20°F to 50°F in the winter with snow 
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Map B 
 
Figure  3.1: The 16 counties involved in the study of campylobacteriosis from 2003-
2006 (map A) and the two participating health departments serving the counties 
(map B) 
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accumulation, and summer temperatures do not rise above 80°F.  The average 
precipitation in Knoxville ranges from less than 3” per month during autumn to more 
than 5” per month during spring.  In the winter, the higher elevations of the Smokey 
Mountains average 8” of rainfall and 20” of snow per month, while autumn months 
average 5” of precipitation per month.  The climate in Knoxville is similar for all 16 
counties in the study area.   
3.1.2 Population 
 The population in the study region was approximately 1,045,400 as of the 2000 
US census.  The region has a mixture of urban and rural areas. The US Census defines an 
urban area as all territory, population and housing units located within areas designated as 
urbanized areas (population greater than 50,000) or urban clusters (population less than 
50,000)[257].  Urbanized areas and urban clusters consist of the census blocks where the 
population density is at least 1,000 people per square mile, the surrounding census blocks 
where the population density is at least 500 people per square mile and any census blocks 
that may connect these clusters.  The most populous county is Knox County which had 
about 382,000 residents in the 2000 census while Union county is the smallest county 
with only 17,800 residents in 2000.  Using United States census definitions for urban and 
rural, there are some counties (Grainger and Union) where none of the population lives in 
an urban area, while in Knox County 87% of the residents are considered to live in an 
urban area.  At the census county division (CCD) and census tract level, there are some 
census tracts and CCDs where 100% of the population is considered to live in an urban 
area.  These are found in Anderson, Blount, Hamblen and Knox Counties.  Census tracts 
are small, relatively permanent statistical subdivisions of a county that are delineated by 
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the U.S. Census Bureau; the optimum size of each tract is 4,000 people but the population 
may be between 1,500 and 8,000 people [258].  A CCD is a county subdivision that has 
been delineated by the U.S. Census Bureau in cooperation with state and local officials 
for the purposes of presenting statistical data that is generally larger than a census tract 
but smaller than a county.  
 The population density in the study region ranges from 38 persons per square mile 
in Morgan County to 751 persons per square mile in Knox County.  Examining 
population density at the census tract level, the highest densities are 9173 and 7832 
persons per square mile in Knox County in two census tracts located near the University 
of Tennessee.  The lowest population densities occur in Claiborne County in a census 
tract with 14 persons per square mile and one in Cocke County with a density of 16 
persons per square mile. 
3.2 Data Sources  
3.2.1  Campylobacter Case Data 
 Campylobacteriosis data collected from January 2003 through December 2006 by 
the East Tennessee Regional and Knox County Health Departments were obtained for 
this study.  Campylobacteriosis has been a notifiable disease in the state of Tennessee 
since 2003 as a result of the state’s participation in FoodNet.  Participation in the 
FoodNet active surveillance system requires that any positive laboratory 
diagnosis/identification of Campylobacter spp. be reported to the local health 
department[259].  Tennessee is one of 10 states participating in this network and as such 
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laboratories and physicians are required by Tennessee law (Tennessee Code Annotated 
68-10-101) to report any Campylobacter positive laboratory results[251] (either stool 
culture or serologic tests).  The campylobacteriosis case definition for this study was 
adapted from the FoodNet definition.  Thus, a case of campylobacteriosis was defined as 
someone who resides in one of the 16 counties in the study area who was ill, and had a 
positive laboratory test result for Campylobacter spp. from either stool culture or 
serologic tests.   
 Once a case is reported, a representative from the health department contacts the 
patient to follow up and administer a standardized questionnaire to obtain information on 
patient demographics, clinical symptoms and possible exposures, (see Appendices A1-A2 
for list of information collected by health departments).  Most of the information 
collected is entered into an electronic database and electronically submitted, via the 
National Electronic Disease Surveillance System, to the Tennessee State Health 
Department and CDC in real time.  The datasets used in this study were requested and 
obtained from the Tennessee State Health Department by each participating health 
department that then provided to the study investigators.  Additional information not 
included in the original electronic database, but present on the health department paper 
case report forms was added to the dataset by the investigators (see Appendix A3).   
 The investigators signed data-user agreements with both participating health 
departments to keep the identification information for each patient in the dataset secure 
and confidential.  Identifiers (name, address and phone number) were removed from the 
dataset prior to analysis.  This study was approved for research involving human subjects 
by the University of Tennessee Internal Review Board (approval # 7634B).  In order to 
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limit the possibility of patient identification from the plots of the geographic distribution 
of cases, geographic analysis was limited to data aggregated at the census tract, CCD, 
county and region levels.   
3.2.2 Demographic and Socio-economic Data 
 The population data for each county, CCD and census tract were obtained from 
the 2000 census to serve as the denominators for the calculation of the prevalence of 
campylobacteriosis.  Age- and sex-specific populations were also obtained from the 
census in order to calculate age- and sex-specific prevalence proportions.  The same 
population was used as the denominator for all 4 years of the study since the population 
increases proposed by the postcensus estimates were small.  The percentage of the 
population living in an urban area (urbancity) was also obtained from the 2000 census at 
the county, CCD and census tract level.  Additionally the total population of the United 
States, grouped by age and sex, was downloaded from the 1990 census to use as the 
standard population for standardization of the prevalences in this study.  The 1990 
population is used to standardize the prevalence in the population because the 2000 
census population was already part of the calculation of the crude prevalence. 
3.2.3 Geographic Data 
 In order to perform geographic analyses, shape files (also called cartographic 
boundary files) were obtained from the Topologically Integrated Geographic Encoding 
and Referencing (TIGER) files on the U.S. Census Bureau website 
(http://www.census.gov/geo/www/cob/bdy_files.html).  TIGER files are the automated 
format that is used by the U.S. Census Bureau to describe land attributes and areas.  
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These shape files were obtained at different geographic scales: state, county, CCD and 
census tract.  The map data were merged (based on the county, CCD or census tract) with 
the demographic census data in order to analyze spatial patterns and associations between 
the geographic location and the prevalence of campylobacteriosis.  The area of each 
polygon (county, CCD and census tract) was also obtained from the TIGER files.  Area 
on the census website is provided in square meters and was converted to square miles.  
This area information was used to calculate human population densities which were 
investigated for the potential association with the prevalence of campylobacteriosis.  
3.3 Evaluation of Campylobacter Data Quality  
 The quality of the electronic datasets provided by each health department was 
assessed by evaluating a random sample of 20% of the cases in each dataset.  The random 
number generator function “RANDBETWEEN” of Microsoft Excel version 2003 
(Microsoft, Redmond, WA) was used to randomly select the cases for analysis.  For each 
health department and each year of the study, the data quality evaluation involved the 
assessment of the completeness and accuracy of data entry.  When comparing each 
patient’s paper case report form with their record in the computer dataset, the paper case 
report form was considered the gold standard.  If the variable field in the computer record 
was blank, but information was included on the case report form, this lack of data was 
considered an incomplete data entry or missing information error.  For the purpose of 
evaluating the dataset, all omissions were counted as errors, since it is impossible to 
know which omissions are due to inadvertent oversight, data loss during conversion, or 
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purposeful exclusion.  A data accuracy error was defined as a discrepancy between the 
paper case report and the computer record.  For both classes of errors, after the error was 
noted, the computer record was corrected before further analyses were performed.  After 
the data quality assessment was complete, the other 80% of the computer records were 
corrected for errors as well.   Due to variations in the computer databases used by the 
state of Tennessee during the study, and a change in the case report form, the number of 
variables analyzed varied by year, (see Appendix A4 for variables included in the dataset 
each year).   
3.4 Data Manipulations  
 New variables were created based on the information obtained in the case report 
forms.  These variables (see Appendix A5) were used to investigate potential associations 
with the prevalence of campylobacteriosis.  The patients were divided into 6 groups 
based on their age: under 5, 5-14, 15-29, 30-49, 50-64, and 65 and over.  This 
classification was selected to correspond with the available groupings in the 1990 and 
2000 censuses.  Patient age groups were also selected based on other factors such as 
grade school attendance, and the normal work and retirement age and the epidemiology 
of campylobacteriosis (highest prevalences reported in children under 5 [239]). To assess 
differences in care seeking behaviors of different population groups (age group and 
geographic location), the variable “time waited before seeking medical care” was created.  
This variable was calculated based on the difference between the date the patient reported 
the onset of their symptoms and the date of the stool culture submission (considered by 
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the health department to be the diagnosis date.)  Similarly, to determine if patients in East 
Tennessee differed in the length of stay in the hospital, the number of days in the hospital 
was calculated from the hospital admission and discharge dates.   
 To compare the severity of disease among different groups (age or geographic 
location) of campylobacteriosis patients in this study, a severity of disease score was 
calculated.  The scale used to establish the severity of disease is shown in Table 3.1, 
which was adopted from a similar scale developed by investigators in a Canadian 
study[260].  The possible severity scores can range from 0-16 and were grouped into the 
following categories: mild 1-7, moderate 8-11 and severe ≥12.  Additionally, the 16 
counties in this study were divided into 4 groups based on the urbanicity (percentage of 
the population living in an urban area) in each county.  Counties were grouped based on 
the urbanicity of the county in order to assess if the prevalence of campylobacteriosis, the 
symptoms experienced or the potential risk factors reported were associated with urban or 
rural areas.  The groupings were determined by dividing the total range of urbanicity 
values (0-87%) by 4, and using this value (22%) as the break point, so the same range of 
urbanicity values are present in each group.  The county groupings are shown in 
Appendix B1.   
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Table  3.1: Scale used to assess the severity of campylobacteriosis in patients from a 
16 county region in East Tennessee, 2003-2006 
Variable Response Points Assigned 
Duration <2 days 1 
 3-5 days 2 
 6-10 days 3 
 11-14 4 
 >15 days 5 
Bloody Stool No 0 
 Yes 3 
Fever No 0 
 Yes 2 
Cramps No 0 
 Yes 1 
Nausea No 0 
 Yes 1 
Vomitting No 0 
 Yes 1 
Muscle Aches No 0 
 Yes 1 
Fatigue No 0 
 Yes 1 
Headache No 0 
 Yes 1 
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3.5 Statistical Analysis 
3.5.1 Summary Statistics 
 Demographic and clinical characteristics together with risk factor variables were 
summarized to describe the overall characteristics of the study population.  Frequency 
distributions were computed for categorical variables (Table 3.2) and reported as the 
percent of patients with the characteristic of interest.  Binomial 95% confidence intervals 
around the percentages were also computed.  Missing or unknown values were excluded 
from these computations.   The treatments reported were categorized by the type of 
treatment received, and class of antibiotic, if applicable.  Proportions were also calculated 
for treatment types.  Patients were included in more than one category if they were 
prescribed multiple classes of antibiotics or classes of treatments.  The normality of 
continuous variables (duration of disease, age, severity of disease, time hospitalized, and 
time waited to seek medical care) was assessed using the Shapiro-Wilk test statistic.  
Median and range were computed for variables that did not conform to a normal 
distribution (duration, age, time hospitalized, and time waited).  The mean and standard 
deviation were used to summarize variables with a normal distribution (severity of 
disease).  Each summary statistic was calculated for the entire study region, each county, 
each year, each age group, and each urbanicity grouping.  Differences in medians were 
tested using the Kruskal-Wallis and Mann-Whitney U tests.  All above calculations were 
performed using SAS version 9.1 (SAS Institute, Cary, NC).  
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Table  3.2: Categorical variables summarized with patient proportions for campylobacteriosis in a 16 
county region of East Tennessee, 2003-2006 
Categorical variables analyzed 
Age group 
Animal exposure 
Contact with other sick individuals 
Drink untreated water 
Handled raw meat 
Hike, camp or swim 
Household member in daycare 
Patient died 
Patient hospitalized 
Prevalence group 
Race 
Severity of illness 
Serotype 
Specimen source 
Symptom variables 
Test ordered 
Travel 
Treatment information 
Urbanicity group 
Water source 
Where treatment sought 
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3.5.2 Assessment of Statistical Associations  
 To assess differences in the distribution of clinical characteristics, potential risk 
factors, or treatments among different patient groups, the percentages calculated for each 
variable above, were compared across groups.  The groups included in these analyses 
were age category, sex, hospitalization status, season, location of where medical care was 
sought, if an antibiotic was prescribed, urbanicity group, and prevalence group.  Possible 
associations between these variables and clinical and potential risk factor variable were 
compared across the different strata of each variable.  Additionally when comparing the 
age groups, the under 5 age group was also compared to the rest of the study population 
over 5 years old.  Clinical symptom variables were compared for statistical associations 
in order to identify combinations of symptoms that were often reported together.  
Categorical variables were compared using Fisher’s Exact test, (for 2x2 comparisons) and 
Pearson χ2 test (for larger tables) in SAS. Overall test p value ≤0.05 was considered 
significant.  Associations were presented as odds ratios with a 95% confidence interval.  
When a variable had multiple categories, one was selected as the reference group which 
was compared with all other groups of that variable.  The reference group selected for 
comparisons was either the first or last group of the variable and the one with the larger 
proportion of patients in the group.    
3.5.3 Prevalence Calculation and Standardization 
 The crude average annual prevalence of campylobacteriosis was calculated for 
each county by dividing the average case count over the four year study period by the 
total population for each county.  The average case count was calculated taking the total 
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number of cases reported in each county over the four year study period and dividing by 
4.  The 2000 census was used as the population for the denominator in all four years of 
the study.  The resulting prevalence was then multiplied by 100,000 to express the 
prevalence as cases per 100,000 persons.   
 The prevalence proportions for each county and CCD were age- and sex-
standardized using the direct method and the 1990 total United States population was 
used as the reference population.  Standardization was performed using the “dstdize” 
command in Stata version 10.0 (Stata Corp., College Station, TX).  The standardized 
prevalence proportion was calculated to remove the influence of age and sex in different 
populations.  This allows for the comparison of the prevalence of campylobacteriosis 
between counties in the study region and the comparison with the reported prevalence of 
other states that have been similarly standardized. 
 After the standardized prevalence for each county was calculated, the counties 
were divided into 4 groups based on this prevalence.  The groupings used were 0-6 cases, 
6-12 cases, 12-18 cases and 18-24 cases per 100,000 persons.  The groupings by county 
are shown in Appendices B2 and B3.  These groupings were determined by dividing the 
maximum prevalence in the region (23 cases/100,000) by 4, so 6 cases per 100,000 was 
used as the cut point in creating the groups.  These groups were created to assess 
differences in the reported potential risk factors, and clinical characteristics based on the 
standardized prevalence.   
 Mean annual age-specific, sex-specific and age- and sex-specific prevalence 
proportions were also calculated.  Exact confidence intervals for the prevalence 
proportions were calculated in Stata.  Comparisons of the prevalence proportions across 
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age groups, sex, or sex and age group were performed using the “prtesti” command in 
Stata for comparing two proportions. Simes method was used to adjust for multiple 
comparisons.  Overall test p value ≤0.05 was considered significant. 
3.5.4 Geographic Analysis 
 GPS (Global Positioning System) coordinates were obtained for each patient 
using the home address provided on the case report form.  These addresses were 
geocoded using GPS Visualizer (www.gpsvisualizer.com).  The geocoding was 
conducted at the health department before the data were released to the investigator to 
ensure that potentially identifying patient information did not leave the health department 
premises.  Point-in-polygon technique of GIS (Geographic Information System) was used 
to join the GPS coordinates of the address of each case to the county, CCD and census 
tract map layers, using ArcView GIS 9.2 (ESRI Redlands, CA).  This procedure 
geographically plotted each case in the appropriate county, CCD or census tract based on 
the geographic location.  After plotting, the sum of the total number of cases reported in 
each county or CCD was calculated.  This sum was used to calculate the prevalence for 
each county.  These area specific prevalences were displayed in ArcView GIS, in order to 
identify areas of high risk.  The CCDs were also grouped into 11 groups by urbanicity 
(0%, 10%, 20%…100%).  The group specific prevalence proportions were calculated, as 
described above (section 3.5.3).  Exact 95% confidence intervals were calculated in Stata 
around each prevalence proportion so as to compare the prevalence proportions for each 
urbanicity grouping of the CCDs.   
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3.5.5 Temporal Analysis 
 The annual prevalence estimates of campylobacteriosis were calculated for each 
year, as described in section 3.5.3.  In order to compare the prevalence of 
campylobacteriosis in East Tennessee region with the state of Tennessee and all of the 
FoodNet sites, the annual case counts of reported cases of campylobacteriosis in 
Tennessee and all of FoodNet were obtained from FoodNet reports[20, 261-265].  The 
annual prevalence for each year, 2003-2006, was also calculated for the state of 
Tennessee and all the sites of the FoodNet surveillance program using postcensus 
estimates for the denominator.  These were the populations described in the published 
reports that were used the denominator for prevalence calculation.  The monthly 
prevalence of campylobacteriosis in East Tennessee was calculated for each of the 48 
months in the study.   Moving averages were calculated over a 3 month period to smooth 
out any short-term fluctuations in the prevalence, and highlight the overall trends or 
cycles.  Additionally, the average number of cases occurring in East Tennessee in each 
calendar month was calculated and the average monthly prevalence determined.  In order 
to assess broader seasonal trends, the months were aggregated into seasons (Spring: 
March, April, May; Summer: June, July, August; Fall: September, October, November; 
Winter: December, January, February).  The average case count was calculated for each 
season and used as the numerator to calculate the average seasonal prevalence.  The 95% 
confidence intervals for each of the prevalence proportions described above were 
computed.  Comparisons of these prevalence proportions between years and season was 
also performed as described under section 2.5.3.   
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4.0 Results 
4.1 Data Quality 
 Among the 20% subset of cases (79 cases) that were randomly selected, the 
overall error rate (data accuracy and missing information errors combined) was 6.5% 
(128/1960).  Data accuracy errors comprised 46.9% (60/128) of the total errors, while 
incomplete data entry or missing information errors comprised the other 53.1% (68/128) 
of the errors identified.  The inaccuracy error rate was 3.0% (60/1960) while the missing 
information error rate was 3.4% (68/1960).  There were some common errors between 
the health departments.  Inaccuracy errors identified in both health departments’ datasets 
were found in the following variables: diagnosis date, zip code and ethnicity. Missing 
information errors common to both health departments’ datasets were observed in: 
address, zip code, ethnicity and race.   
 The overall error rate for the East Tennessee Regional Health Department 
(ETRHD) was 4.7% (51/1090); 70.6% (36/51) of the errors were in data accuracy and 
29.4% (15/51) were missing information errors.  For the Knox County Health 
Department (KCHD), the overall error rate was 8.8% (77/870), with 31.2% (24/77) of the 
errors in data accuracy and 68.8% (53/77) were missing information errors.  The overall 
KCHD error rate was significantly (p=0.0002) higher than that of the ETRHD. Table 4.1 
shows the error rates for each health department and year. 
 The most common variables with errors for the ETRHD were “ethnicity” (13 
inaccuracies and 2 cases with missing information), and “source of the specimen tested” 
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Table  4.1: Data quality evaluation of 20% sample of 8 campylobacteriosis datasets from East Tennessee Regional and 
Knox County Health Departments, 2003-2006 
Health 
Department 
Year Number of 
variables in 
dataset 
Cases with 
errors/Cases 
analyzed (%) 
Total # of 
fields 
analyzed  
Overall error 
percentage 
(total # errors) 
Inaccuracy 
error 
percentage  
(# of 
inaccuracies) 
Percentage of 
missing 
information errors 
(# of incomplete 
entries) 
2003 22  6/16 (37.5) 352 4.26 (15) 3.41 (12) 0.85 (3) 
2004 24  10/13 (76.9) 312 8.33 (26) 4.83 (17) 2.88 (9) 
2005 28  7/12 (58.3) 336 2.98 (10) 2.08 (7) 0.89 (3) 
East 
Tennessee 
2006 28  0/4 (0) 112 0 0 0 
2003 24  8/11 (72.7) 264 5.68 (15) 3.03 (8) 2.65 (7) 
2004 24  8/8 (100) 192 18.2 (35) 6.25 (12) 12.0 (23) 
2005 28  7/7(100) 196 9.18 (18) 0.51 (1) 8.67 (17) 
Knox 
County 
2006 28  6/8 (75) 224 4.02 (9) 1.34 (3) 2.68 (6) 
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(10 inaccuracies and 1 case with missing information).  The most common inaccuracy 
errors in the ETRHD dataset included listing an ethnicity when none was specified on the 
case report form, or listing the blood as the specimen when stool was specified on the 
case report form. Other variables with inaccuracy errors identified only in the ETRHD 
datasets, included: city, county, zip code, race, diagnosis date, source of report, whether 
the patient was hospitalized, hospital name, the date of discharge from the hospital and 
the status of the patient (hospitalized or outpatient).  Variables with missing information 
errors in the ETRHD datasets were: serotype, race, address, zip code, and city.  The 2006 
analysis was performed partway through the year so only 4 cases were evaluated for data 
quality, and no inaccuracies or missing information were observed (Table 4.1). 
 For the KCHD, the most common variables with errors were ethnicity (8 errors in 
data accuracy and 6 missing information errors) and travel (3 errors in data accuracy and 
8 missing information errors).  Other variables with errors in accuracy identified only in 
the KCHD datasets were: diagnosis date, zip code, street address, the hospital discharge 
date and patients outcome (alive or dead).  Variables that had missing information in the 
computer dataset were: home phone, physician name, street address, zip code, race, travel 
dates, and middle name. 
 Table 4.2 shows the percentage of missing or unknown values for each variable in 
the corrected dataset.  Certain variables have a higher percentage of unknowns due to a 
change in the data collection form.  For example, the “household drinking water source” 
and the “location where the patient sought medical care” fields were removed from the 
new case report form introduced in 2006.  Additionally, the question about treatment was 
changed from “any treatment received” to “any antibiotic given”.  The wording about  
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Table  4.2: Percentage of patients with missing or unknown information for each 
variable in the corrected campylobacteriosis dataset from a 16 county region in East 
Tennessee, 2003-2006 (n=436) 
Variable Number of missing or unknowns values(%) 
Race 22 (5.0) 
Specimen source 7 (1.6) 
Serotype 214 (49.1) * 
Test ordered 28 (6.4) 
Patient hospitalized 4 (0.9) 
Patient died 111 (25.5) 
Symptom variables 39 (8.9) 
Where treatment sought 228 (52.3) † 
Travel 37 (8.5) 
Animal exposure 36 (8.3) 
Handled raw meat 58 (13.3) 
Household member in daycare 40 (9.2) 
Contact with other sick 48 (11.0) 
Hike, camp or swim 40 (9.2) 
Drink bad water 51 (11.7) 
Water source 172 (39.4) ‡ 
Treatment information 126 (28.9) 
*
 Serotype not identified, listed as Campylobacter spp. 
† 81 unknown, 147 not on case report form 
‡ 5 unknown, 167 not on case report form 
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drinking untreated water was changed as well from “Drink from a spring, stream, or 
lake?” to “Did the patient drink untreated water in the 7 days prior to onset of illness?” 
These changes led to a larger percentage of unknowns in the corrected 2006 dataset 
compared to other years. 
4.2 Descriptive Statistics 
4.2.1 Demographic Characteristics of Patients 
 A total of 436 cases of campylobacteriosis were reported in the 16 counties over 
the 4 year study period.  The median age of all cases was 26 (range 1 month to 89 years).  
There was no significant (p=0.08) difference in the median age of the cases across all 
years of the study.  The majority of cases (53.7%, 234/436) were male; the median age 
for males was 23.5 while the median age for females was 30.5, but this difference was 
not statistically significant (p=0.155).  Most cases (95.6%, 396/414) were classified as 
white.  Only 3.9% occurred in children aged 6 months or younger, but 15.4% occurred in 
children aged 1 year or younger.  Males accounted for 59% of the under 5 age group, 
60.7% of the cases in the 5-14 age group but only 42.9% of the cases in the 65 and over 
age group.   
 There was a significant (p=0.0004) difference in the median age of patients when 
the counties were grouped based on urbanicity (Table 4.3).  There was also a significant 
(p=0.0210) difference in the median age of the patients when the counties were grouped 
based on disease prevalence.  Although the median age is lower in the rural and higher 
prevalence counties, the percentage of the population that is under 5 years old is not  
 69 
Table  4.3: Distribution of campylobacteriosis cases based on the prevalence of 
disease or the percentage of the county that is considered urban in a 16 county 
region in East Tennessee, 2003-2006 (n=436) 
Grouping 
Variable 
No of 
cases (%) 
Percentage of  
population under 
5 years of age 
Median 
age 
Crude Group 
Specific 
Prevalence 
Urbanicity Group     
    66% or more 184 (42.2) 6.2 31.5 10.4 
    44-66% 116 (26.6) 5.7 31.0 10.8 
    22-44% 102 (23.4) 6.0 16.5** 8.9 
    22% or less 34 (7.8) 6.4 5.5** 10.7 
Prevalence Group     
     0 – 6 * 25 (5.73) 6.3 24.0 - 
     6 – 12 268 (61.5) 6.1 29.0 - 
     12 – 18 90 (20.6) 5.9 26.5 - 
     18 – 24 53 (12.2) 6.1 8.0‡ - 
*Listed as cases per 100,000 population 
- Not applicable 
**Significantly different (Simes corrected p=0.025) 
‡Group 4 (18-24) is significantly different from group 2 (6-12) 
     (Simes corrected p=0.0083) 
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significantly different among the counties.  The median age also varied greatly among the 
16 counties in the study.  The county with the lowest median age (3) was Cocke County, 
while Hamblen County had the highest median age (39 years) (Table 4.4). 
4.2.2 Care Seeking and Diagnostic Characteristics 
 The median delay in seeking a physician’s care from the onset of symptoms 
reported by patients was 4 days (range = 1 – 181 days).  Most patients either sought care 
at a doctor’s office (46.6%, 97/208) or an emergency room (ER) (47.6%, 99/208), (Table 
4.5).  Most (99.5%, 427/429) patients submitted a stool sample (Table 4.5) and stool 
culture was the predominant test ordered (93.4%, 381/408), but additional laboratory tests 
were ordered in some cases.  The species of Campylobacter was identified in 50.9% 
(222/436) of cases.  The most commonly identified species was Campylobacter jejuni 
(98.7%), followed by 2 cases of C. coli (0.9%) and the co-infection of C. jejuni and C. 
coli in 1 case (0.45%).  Twenty-five percent of cases had missing information regarding 
the disposition (alive or deceased) of the patient after infection with campylobacteriosis, 
but of those with known information, 1 patient died. 
4.2.3 Clinical Description of Cases 
 The most common clinical symptoms and signs reported were: diarrhea (97.5%), 
fever (62.5%), cramps (56.2%) and nausea (47.4%), (Table 4.6).  Specific combinations 
of symptoms tended to occur in some patients.  Those patients who reported nausea 
(47.4%) were also likely to report vomiting (38.5%); 25.9% reported both (χ² =39.8026, 
p=<0.0001).  Patients who reported suffering from headaches were also likely to report  
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Table  4.4: Median age of cases reported in each county in a 16 county region in East 
Tennessee, 2003-2006 
County Median age of cases 
reported  
Range of ages reported 
Anderson 38* 1 – 65 years 
Blount 30.5 7 months – 74 years 
Campbell 33 10 months – 70 years 
Claiborne 23 1 month – 87 years 
Cocke 3 1 month – 75 years 
Grainger 6 2 months – 58 years 
Hamblen 39 6 – 75 years 
Jefferson 10 1 month – 84 years 
Knox 30 1 month – 89 years 
Loudon 30 2 months – 62 years 
Monroe 9 7 months – 69 years 
Morgan 13.5 1 – 55 years 
Roane 15.4 2 months – 39 years 
Scott 13.5 1 – 66 years 
Sevier 24.0 8 months – 71 years 
Union 4.0 1 – 75 years 
*No significant differences were identified between all counties due to the number of 
comparisons (120) 
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Table  4.5: Physician visit location, laboratory and hospitalization information for 
reported cases of campylobacteriosis in a 16 county region in East Tennessee, 2003-
2006 
Variable Number of cases (%) 
Location patient sought treatment (n=208)  
Doctor’s Office 97 (46.6) 
Emergency Room 99 (47.6) 
Emergency Room and Doctor’s Office 10 (4.8) 
Urgent Care Clinic 2 (1.0) 
Source of specimen used to identify Campylobacter (n=429)  
Stool 427 (99.5)  
Blood 2 (0.5) 
Test ordered by physician (n=408)  
Culture 381 (93.4) 
Culture and Serological 19 (4.6) 
Culture and Ova & Parasite 4 (1.0) 
Culture, Ova & Parasite and Serological 1 (0.2) 
Other 1 (0.2) 
Ova & Parasite 1 (0.2) 
Serological 1 (0.2) 
Campylobacter serotype identified (n=222)  
Jejuni 219 (98.6) 
Coli 2 (0.9) 
Coli and Jejuni 1 (0.4) 
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Table  4.6: Self reported clinical signs among patients with campylobacteriosis in a 
16 county region in East Tennessee, 2003-2006  
Variable No cases (%) 
Symptom (n=397)  
Diarrhea 387 (97.5) 
Fever 248 (62.5) 
Cramps 223 (56.2) 
Nausea 188 (47.4) 
Vomiting 152 (38.5) 
Bloody Stool 150 (37.8) 
Fatigue 122 (30.7) 
Muscle Aches 122 (30.7) 
Headache 106 (26.7) 
Chills* 32 (8.1) 
Severity (n=374)  
Mild (1-7) 179 (47.9) 
Moderate (8-11) 158 (42.2) 
Severe (≥12) 37 (9.9) 
*Chills as a symptom was not introduced as a check box on the case reports until 2006, but could be added 
under “Other” prior to 2006 
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fatigue; 15.4% reported experiencing both (χ² =48.8542, p=<0.0001).  Other associated 
symptoms were cramps and nausea (χ² =48.5601, p=<0.0001) and headache and muscle 
aches (χ² =42.2214, p=<0.0001).  Fever was a commonly reported symptom with 62.5% 
(248/397) of patients reporting experiencing a fever.  Not all cases who reported fever 
gave the maximum temperature.  Only 70.6% (175/248) reported the temperature reading 
of the fever.  The median high temperature was 102.0°F (range: 99.0 - 105.0°F).     
 Certain symptoms of campylobacteriosis were significantly associated with the 
age of the patient (Table 4.7).  The youngest age group (under 5) was used as the 
reference group in all comparisons.  Bloody stool was the only symptom for which all 
older age groups had lower odds of reporting the symptom when compared with the 
under 5 age group.  For the other symptoms listed above the older age groups were more 
likely to report experiencing the symptom.  Symptoms were also statistically associated 
with the urbanicity grouping of the county where the patient resided (Table 4.8).  When, 
the most urban category (66-88% urban) was used as the reference group, the more rural 
counties had higher odds of reporting bloody stool, nausea, vomiting, cramps, and 
fatigue.  
 The median duration of disease was 7 days (range: 1-60, 180 days); this was the 
same for both males and females.  There was no significant difference in the duration of 
symptoms when the counties were grouped by urbanicity or by the prevalence of disease.  
The mean severity of disease score was 7.6 ±3.1 (severity score was normally distributed) 
and this was the same for males and females.  Patients with a score of 1-7 were 
considered mild (47.9%), 8-11 moderate (42.2%) and a score of 12 or more was  
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Table  4.7: Odds ratios of statistical associations between disease characteristics and 
the age group of the patient in a 16 county region in East Tennessee, 2003-2006 
Comparison Variable Age Group* Odds Ratio  
(Confidence Interval) 
Exact p value 
5-14 years old 2.9 (1.2-6.7) 0.015 
15-29 years old 1.0 (0.40-2.7) 1 
30-49 years old 2.1 (0.97-4.4) 0.068 
50-64 years old 4.4 (1.9-9.7) 0.0004 
65 years and older 11.5 (4.6-28.4) 0.0004 
Was the patient 
hospitalized? (yes) 
5 years and older† 2.8 (1.5-5.5) 0.0008 
5-14 years old 0.60 (0.30-1.2) 0.21 
15-29 years old 0.72 (0.37-1.4) 0.33 
30-49 years old 0.37 (0.21-0.66) 0.0009 
50-64 years old 0.24 (0.11-0.51) 0.0001 
65 years and older 0.21 (0.084-0.53) 0.0006 
Bloody Stool (yes) 
5 years and older 0.41 (0.26-0.66) 0.0002 
5-14 years old 17.1 (3.7-79.6) <0.0001 
15-29 years old 36.5 (8.2-162.0) <0.0001 
30-49 years old 29.5 (6.9-126.2) <0.0001 
50-64 years old 21.1 (4.6-96.0) <0.0001 
65 years and older 9.5 (1.8-49.7) 0.005 
Headache  
5 years and older 24.0 (5.8-99.5) <0.0001 
5-14 years old 3.2 (1.4-7.0) 0.004 
15-29 years old 9.3 (4.4-19.7) <0.0001 
30-49 years old 8.2 (4.2-16.1) <0.0001 
50-64 years old 6.1 (4.6-96.0) <0.0001 
65 years and older 4.6 (2.0-10.8) 0.0005 
Nausea  
5 years and older 6.4 (3.6-11.5) <0.0001 
5-14 years old 3.2 (1.5-6.6) 0.0019 
15-29 years old 7.6 (3.6-15.8) <0.0001 
30-49 years old 6.8 (3.7-12.7) <0.0001 
50-64 years old 3.3 (1.7-6.7) 0.0008 
65 years and older 1.9 (0.83-4.2) 0.14 
Cramps  
5 years and older 4.5 (2.7-7.5) <0.0001 
5-14 years old 1.8 (0.62-5.4) 0.26 
15-29 years old 6.1 (2.5-14.8) <0.0001 
30-49 years old 9.0 (4.0-20.6) <0.0001 
50-64 years old 10.8 (4.4-26.4) <0.0001 
65 years and older 4.3 (1.5-12.0) 0.0078 
Muscle Aches  
5 years and older 6.4 (3.0-13.8) <0.0001 
5-14 years old 2.2 (0.89-5.6) 0.09 
15-29 years old 6.4 (2.9-14.3) <0.0001 
30-49 years old 3.6 (1.7-7.6) 0.0006 
50-64 years old 7.0 (3.1-16.0) <0.0001 
65 years and older 3.9 (1.5-10.1) 0.008 
Fatigue 
5 years and older 13.0 (6.7-25.50 <0.0001 
*Reference Group: Youngest age group (under 5 years old) 
†Under 5 age group compared to all groups over 5 years old  
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Table  4.8: Associations between symptoms of campylobacteriosis and the urbanicity 
of the county of residence for a 16 county region in East Tennessee, 2003-2006 
Variable Urbanicity 
Group* 
Odds Ratio  
(Confidence Interval) 
Exact p 
value 
44-66% urban 1.8 (1.1-3.1) 0.025 
22-44% urban 2.2 (1.3-3.7) 0.0042 
Bloody Stool 
0-22% urban 3.2 (1.5-7.1) 0.0053 
44-66% urban 2.1 (1.2-3.5) 0.0054 
22-44% urban 1.9 (1.1-3.3) 0.018 
Fever 
0-22% urban 1.2 (0.55-2.6) 0.7 
44-66% urban 2.8 (1.6-4.8) 0.0004 
22-44% urban 1.5 (0.83-2.8) 0.2 
Headache 
0-22% urban 1.8 (0.75-4.3) 0.2 
44-66% urban 3.6 (2.2-6.0) <0.0001 
22-44% urban 1.4 (0.81-2.3) 0.3 
Nausea 
0-22% urban 2.6 (1.2-5.6) 0.025 
44-66% urban 1.5 (0.90-2.5) 0.15 
22-44% urban 2.4 (1.4-4.0) 0.0014 
Vomiting 
0-22% urban 2.6 (1.2-5.6) 0.02 
44-66% urban 3.6 (2.2-6.2) <0.0001 
22-44% urban 1.2 (0.72-2.0) 0.5 
Cramps 
0-22% urban 4.4 (1.8-10.7) 0.0007 
44-66% urban 2.5 (1.5-4.4) 0.0009 
22-44% urban 2.6 (1.5-4.6) 0.0013 
Muscle Aches 
0-22% urban 1.9 (0.83-4.5) 0.15 
44-66% urban 6.4 (3.5-12.0) <0.0001 
22-44% urban 5.2 (2.7-9.8) <0.0001 
Fatigue 
0-22% urban 6.4 (2.7-15.0) <0.0001 
*Reference Group: most urban (66-88% urban) 
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considered severe (9.9%) as shown in Table 4.6.   The majority of the 37 cases in the 
severe category were in the 30-49 age group (15/37, 40.5%).  The mean severity score 
was highest in the 15-29 age group at 8.6 (95% CI: 7.7 - 9.4) and the lowest in the 65 and 
over age group at 6.5 (95% CI: 5.3 - 7.6).  
4.2.4 Treatment 
 A wide rage of therapeutic agents were prescribed, namely: broad spectrum 
antibiotics, antiprotoazoals and antivirals (Table 4.9).  Most (73.6%) patients were 
prescribed only 1 therapeutic agent, 15.5% were prescribed 2, 3.2% were prescribed 3 
and 7.7% had no therapeutic agent prescribed.  Antibiotics were the most commonly 
prescribed therapeutic agents with 84.5% of patients reporting receiving at least 1 
antibiotic.  Of the patients who knew the class of antibiotics prescribed, fluoroquinolones 
and macrolides were the two most common.  
4.2.5 Hospitalization 
 Of the 432 cases with known hospitalization information, 101 (23.4%) were 
hospitalized.  The median length of stay in the hospital was 2 days (range:  <1 to 11).  
During the 4 years of the study, 2004 had the highest percentage of annual 
hospitalizations (26.4%).  The annual, seasonal, and monthly hospitalization percentages 
are shown in Table 4.10 along with the 95% confidence interval.  Among the four 
seasons, the highest percentage of hospitalizations was observed in summer 28.4% 
(46/162) but this was not significantly different from other seasons.  September had the 
highest percentage of cases hospitalized at 38.9% (14/36); September and July (30.9%, 
21/68) each had a significantly higher monthly percentage hospitalizations than the  
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Table  4.9: Treatments reported by campylobacteriosis patients in a 16 county region 
of East Tennessee, 2003-2006 (n=310) 
Treatment type No cases reporting treatment(%)* 
Antibiotic  262 (84.5)  
           Β-Lactam  4 (1.5)  
           Cephalosporin  5 (1.9) 
           Fluoroquinolone 95 (36.3) 
           Macrolide 84 (32.1) 
           Sulfonamide 5 (1.9) 
           Tetracycline 5 (1.9) 
           Unknown Antibiotic 73 (27.9) 
Intravenous fluids  31 (10.0) 
No treatment 18 (5.8) 
Antidiarrheal/AntiNausea 14 (4.5) 
Antiprotazoal 14 (4.5) 
Oral rehydration 6 (1.9) 
Other† 11 (3.6) 
Number of therapeutic agents prescribed   
           1 therapeutic agent 228 (73.6) 
           2 therapeutic agents 48 (15.5) 
           3 therapeutic agents 10 (3.2) 
*
 Percentages sum to over 100 since some therapeutic agents  were prescribed in combination 
† 
“Other” includes: pain drugs (3), proton pump inhibitors (2), steroids (2), appendectomy (2), antiviral (1), 
and H2 receptor antagonist (1) (blocks histamine receptor- 2 to decrease stomach acid production) 
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Table  4.10: Temporal and seasonal proportions of patients hospitalized due to 
campylobacteriosis in a 16 county region in East Tennessee, 2003-2006 (n=436) 
Time frame Total number 
of cases (%) 
Number of cases 
hospitalized (%) 
Confidence interval for 
percentage of cases 
hospitalized 
Year    
2003 140 (32.1) 36 (25.7)  18.7-33.8 
2004 110 (25.2) 29 (26.4) 18.4-35.6 
2005 97 (22.2) 21 (21.6) 13.9-31.2 
2006 89 (20.4) 17 (19.1) 11.5-28.8 
Season*    
Summer 162 (37.2)  46 (28.4) 21.6-36.0 
Fall 103 (23.6) 21 (20.4) 13.1-29.5 
Winter 91 (20.9) 18 (19.8) 12.2-29.4 
Spring 80 (18.4) 18 (22.5) 13.9-33.2 
Month    
January 26 (6.0)  2 (7.6)  9.4-25.1 
February 29 (6.6) 5 (17.2) 5.8-35.8 
March 27 (6.2) 7 (25.9) 11.1-46.3 
April 24 (5.5) 6 (25.0) 9.7-46.7 
May 29 (6.6) 5 (17.2) 5.8-35.8 
June 48 (11.0) 14 (29.2) 17.0-44.1 
July 68 (15.6) 21 (30.9)** 20.2-43.2 
August 46 (10.6) 11 (23.9) 12.5-38.8 
September 36 (8.3) 14 (38.9)** 23.1-56.5 
October 29 (6.6) 5 (17.2) 5.8-35.8 
November 38 (8.7) 2 (5.3)** 0.6-17.7 
December 36 (8.3) 11 (30.6) 16.3-48.1 
*Seasons were defined as, Summer: June, July, August, Fall: September, October, November, Winter: 
December, January, February, Spring: March, April, May 
**June and September significantly differed from November 
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month of November (5.3, 2/38), which had the lowest percentage of hospitalized 
campylobacteriosis patients.   
 The oldest age group (65 and above) experienced the highest percentage of 
hospitalization (60.0%), followed by age groups 50-64 (36.2%) and 5-14 (27.3%).  The 
lowest percentages of hospitalizations were observed in the under 5 age group (11.5%), 
followed by 15-29 (11.9%) and 30-49 (21.2%).  Hospitalization proportions were 
significantly associated with age (p=<0.0001).  Using the under 5 age group as the 
reference group, these associations are shown in Table 4.7.  All groups except the 15-29 
age group had significantly higher odds of being hospitalized than the under 5 age group.  
Patients over 5 years old had much higher odds of hospitalization than those under 5 
(OR: 2.8, CI: 1.5-5.5).  The most rural counties had the lowest percentage of cases 
hospitalized at 12.0% (4/34; CI 3.3 – 27.4), while the counties that were 44-66% urban 
had the highest percentage of cases hospitalized at 29.6% (34/115; CI 21.4 – 38.8%).  
This difference was statistically significant (p=0.036). 
4.2.6 Risk Factors for Campylobacteriosis  
 Exposure to animals was the most commonly reported risk factor with 74.2% of 
cases reporting being exposed to one or more animals in the week (up to 10 days) prior to 
the onset of symptoms (Table 4.11).  Of those exposed to animals, the most common 
animal was dogs (79.5%) and the least common was turkeys (0.7%).   Animal exposure 
was significantly associated (p=0.0041) with the age group of the patient, with patients in 
the 65 and older age group having significantly lower odds of reporting animal exposure 
than the under 5 year old patients (Table 4.12).  None of the other age groups had  
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Table  4.11: Exposure to suspected risk factors for acquiring campylobacteriosis in 
the 10 days prior to symptom onset as reported by patients in a 16 county region in 
East Tennessee, 2003-2006 
Risk Factor No of cases (%) 
Any animal exposure (n=400) 297 (74.2)  
    Specific animal exposure (n=297)  
Cats 98 (33.0) 
Cattle 17 (5.7) 
Chickens 29 (9.8) 
Dogs 236 (79.5) 
Goats 11 (3.7) 
Horses 4 (1.4) 
Lizards 4 (1.4) 
Rodents 13 (4.4) 
Turkeys 2 (0.7) 
Turtles 4 (1.4) 
Handle raw meat/poultry (n=378) 80 (21.2) 
Have a household member in daycare (n=394) 33 (8.4) 
Have contact with someone with similar symptoms (n=388) 57 (14.7) 
Hike, camp, fish or swim (n=394) 75 (19.0) 
Drink from a spring, stream, or untreated water (n=385) 40 (10.4) 
Travel (n=399) 86 (21.6) 
Destination –International 45 (11.3) 
Destination – Domestic 41 (10.3) 
Water source (n=262)  
City 172 (65.7) 
Well 82 (31.3) 
Spring 8 (3.1) 
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Table  4.12: Odds ratios of statistical associations between risk factors for 
campylobacteriosis and the age group of the patient, in a 16 county region in East 
Tennessee, 2003-2006 
Risk Factor  Age Group* Odds Ratio  
(95% Confidence Interval) 
Exact  
p value 
5-14 years old 1.9 (0.72-5.1) 0.26 
15-29 years old 0.99 (0.45-2.2) 1 
30-49 years old 0.75 (0.39-1.4) 0.42 
50-64 years old 0.54 (0.26-1.1) 0.12 
Animal Exposure (yes) 
65 years and older 0.29 (0.13-0.66) 0.004 
5-14 years old 1.0 (0.72-5.1) 1 
15-29 years old 10.0 (3.2-31.6) <0.0001 
30-49 years old 12.8 (4.3-37.9) <0.0001 
50-64 years old 9.4 (2.9-30.0) <0.0001 
Handle Raw Meat 
65 years and older 2.8 (0.66-11.9) 0.22 
5-14 years old 0.59 (0.18-1.9) 0.58 
15-29 years old 0.22 (0.048-1.0) 0.049 
30-49 years old 0.94 (0.41-2.2) 1 
50-64 years old 0.056 (0.0032-0.96) 0.002 
Household Member in 
Daycare 
65 years and older 0.19 (0.024-1.5) 0.11 
*Reference group: Youngest age group (under 5 years old) 
 
 83 
significant associations with animal exposure when compared with the reference age 
group. 
 International travel was reported by 52.3% of patients reporting travel, while the 
other 47.7% reported domestic travel.  Travel outside the area of residence was 
significantly associated with the age of the patient (p=0.0055), the urbanicity of the 
county (p<0.0001), and the prevalence grouping of the county (p=0.0007) (Table 4.13).  
All age groups except the 5-14 year olds had higher odds of reporting travel outside the 
area when compared with the under 5 years age group.   Similarly, patients in the more 
rural counties had lower odds of reporting travel than those in the most urban counties 
and patients from counties of lower prevalence had increased odds of travel outside the 
area of residence when compared with patients who reside in counties of higher 
prevalence. 
 Having a private well as the household drinking water source was reported by 
31.3% of all cases.  Drinking untreated water (not limited to the household water source) 
was significantly associated with the urbanicity of the county of residence (p=0.0002)   
Patients in the middle urbanicity groups (22-44% and 44-66% urban) had lower odds of 
reporting drinking untreated water at 0.37 (95% CI: 0.15-0.95) and 0.25 (95% CI: 0.094-
0.69) respectively, when compared with cases who lived in the most urban counties.  The 
most rural counties were not significantly different in the percentage of patients who 
reported drinking untreated water when compared to the reference group – the most 
urban counties. 
 Hiking, camping, fishing or swimming in the 10 days prior to the onset of 
symptoms was reported by 19% of the cases.  Engaging in one of the four activities was  
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Table  4.13: Associations between travel outside the area and age group, urbanicity 
group and the prevalence group for a 16 county region in East Tennessee, 2003-2006 
Grouping 
Variable 
Group* Odds Ratio 
(95% Confidence 
Interval) 
Exact p 
value 
5-14 years old 2.3 (0.84-6.2) 0.11 
15-29 years old 5.1 (2.1-12.0) 0.0001 
30-49 years old 3.3 (1.4-7.4) 0.0048 
50-64 years old 2.3 (1.0-6.9) 0.047 
Age Group 
65 years and older 4.0 (1.4-10.8) 0.0095 
44-66% urban 0.36 (0.20-0.66) 0.0008 
22-44% urban 0.25 (0.12-0.51) <0.0001 
Urbanicity Group 
0-22% urban 0.20 (0.059-0.69) 0.0053 
0-6 cases/100,000 5.5 (1.2-24.6) 0.025 
6-12 cases/100,000 5.6 (1.7-18.6) 0.0013 
Prevalence Group 
12-18 cases/100.000 1.9 (0.50-7.3) 0.54 
*Reference Groups:  
Age – under 5 age group, Urbanicity – 66-88% urban, Prevalence – 18-24 cases 
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significantly associated (p=0.0009) with the season of the year.  Cases in the summer had 
2.3 (95% CI: 1.1 - 4.6) times higher odds of reporting engaging in one of these activities 
than those in the fall and 4.7 (95% CI: 1.9-11.6) times higher odds than those in the 
winter.  There was no significant difference (p=1.0) in the frequencies of reports of these 
activities between summer and spring. 
 While handling raw meat was only reported by 21.2% of the cases, it was 
significantly associated with sex (p=0.017) and age (p=0.0002).  Women had 1.5 (95% 
CI: 1.0-2.7) times higher odds of reporting handling raw meat than men.  Patients in the 
middle age groups (15-29, 30-49 and 50-64) had higher odds of reporting exposure to 
raw meat compared to the under 5 age group (Table 4.12).  There was no significant 
difference in the odds of handling raw meat between the under 5 age group and the 5-14 
and 65 and over age groups.  Having a household member in daycare was also 
significantly associated (p=0.013) with the age group of the patient.  Patients in the 15-29 
and 50-64 age groups had significantly lower odds of reporting a family member in 
daycare than the under 5 age group.  The other comparisons were not significant. 
4.2.7 Prevalence Distribution 
 The mean crude prevalence of campylobacteriosis in the 16 county region during 
the study period was 10.4 per 100,000 (95% CI: 9.5 - 11.4).  The crude prevalence 
estimate for all FoodNet sites in the US during the same period was 12.7 per 100,000 
(95% CI: 12.4 - 13.0), while that of the entire state of Tennessee was 7.40 per 100,000 
(95% CI: 6.7 - 8.1).  
 The county level age- and sex-standardized prevalences of campylobacteriosis are 
presented in Figure 4.1.  Grainger and Jefferson counties had the highest prevalences at 
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Figure  4.1: Age- and sex-standardized prevalence of campylobacteriosis and 95% confidence intervals for a 16 county 
region in East Tennessee, 2003-2006 
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22.9 and 21.8 cases per 100,000 population, respectively; while Hamblen and Roane 
counties had the lowest at 3.8 and 4.4 cases per 100,000 population, respectively.  Some 
counties in the study area had prevalence values that were much higher than the national 
average.  Age- and sex-standardized prevalence estimates for each CCD are show in 
Figure 4.2; no cases were reported in some CCDs (white) and the prevalence of 
campylobacteriosis was the highest in the Philadelphia CCD of Loudon County and the 
Washburn CCD of Grainger County at 67 and 57 cases per 100,000, respectively (dark 
blue).  The CCDs were grouped based on the urbanicity of the residents, in 10% 
increments. The prevalence of campylobacteriosis in these groups ranges from 7.6 – 14.0 
cases per 100,000, but none of the groups differed significantly and there was no trend in 
the prevalence of campylobacteriosis. 
 The age- and sex-specific prevalence estimates of campylobacteriosis for the 
entire study region are shown in Figure 4.3 for each age group.  The highest reported 
prevalence estimate was observed among male children under the age of 5 at 47.7 cases 
per 100,000 (95% CI: 36.6 - 61.2), and the lowest was reported among females aged 65 
and older at 5.95 cases per 100,000 (95% CI: 3.6 - 9.2).  There was no statistically 
significant (p>0.05) difference in the prevalence of campylobacteriosis between males 
and females across all age groups. 
4.2.8 Temporal Patterns 
 The mean annual prevalence of reported cases of campylobacteriosis in East 
Tennessee gradually declined over the 4 year study period, while the prevalence in the 
US and the state of Tennessee remained approximately the same (Figure 4.4).  The 
overall crude prevalence of campylobacteriosis was 13.39 cases per 100,000 population 
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Figure  4.2: Age- and sex-standardized prevalence of campylobacteriosis for each census county division in a 16 county 
region in East Tennessee, 2003-2006 
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Figure  4.3: Age- and sex-specific prevalence of campylobacteriosis in a 16 county region in East Tennessee, 2003-2006. 
(Error bars represent the 95% confidence interval) 
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Figure  4.4: Annual prevalence of campylobacteriosis for a 16 county region in East Tennessee, the entire state of 
Tennessee and all US FoodNet sites, 2003-2006.  (Error bars represent the 95% confidence interval) 
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in 2003 in ET.  This prevalence was not statistically different from the prevalence of 
disease for the entire FoodNet area in the United States, of 12.60 cases per 100,000 
(p=0.4759), but was significantly (p<0.0001) different from the prevalence of disease in 
the state of Tennessee (7.81 per 100,000).  By 2006 the prevalence of disease in ET had 
decreased to 8.51 per 100,000.  This was significantly lower (p=0.0002) than the 
prevalence in the US (12.71 per 100,000) but not significantly (p=0.227) different from 
that of the state of Tennessee (7.40 per 100,000).  The annual prevalence of 
campylobacteriosis in ET in 2003 was significantly different from the prevalence in 2005 
(p=0.005) and 2006 (p=0.0008).  The critical p-value of Simes correction for multiple 
comparisons was 0.0167.  There was no significant difference in the prevalence of 
disease among the other years of the study. 
 The monthly prevalence of campylobacteriosis and 3-month moving average are 
shown in Figure 4.5.  The linear regression line shows an overall decreasing temporal 
trend in the prevalence of disease in the region.  Over the course of the study, the mean 
monthly prevalence had a decreasing trend at a rate of 0.0085 cases (per 100,000) per 
month.  A consistent peak in the reported prevalence of campylobacteriosis occurred in 
the summer months of each year.  In November of 2004 there appeared to be an off-
seasonal peak in the prevalence of campylobacteriosis, but this peak was not significantly 
higher than the prevalence during the other winters of the study period (Figure 4.6).  The 
average summer prevalence (3.9/100,000) was significantly higher (p=0.0003) than that 
in the fall (2.5/100,000), winter (2.2/100,000, p<0.0001) and spring (1.9/100,000, 
p<0.0001).  The summer of 2003 had highest seasonal prevalence at 5.6 cases per 
100,000 (CI: 4.2-7.2), while the spring of 2004 had the lowest at 1.3 cases per 100,000 
 92 
0
0.5
1
1.5
2
2.5
Ja
n-
03
Ma
r-0
3
Ma
y-0
3
Ju
l-0
3
Se
p-0
3
No
v-
03
Ja
n-
04
Ma
r-0
4
Ma
y-0
4
Ju
l-0
4
Se
p-0
4
No
v-
04
Ja
n-
05
Ma
r-0
5
Ma
y-0
5
Ju
l-0
5
Se
p-0
5
No
v-
05
Ja
n-
06
Ma
r-0
6
Ma
y-0
6
Ju
l-0
6
Se
p-0
6
No
v-
06
Month
P
r
e
v
a
l
e
n
c
e
 
(
p
e
r
 
1
0
0
,
0
0
0
 
p
o
p
u
l
a
t
i
o
n
)
crude prevalence 3 month moving average Linear (crude prevalence)
 
Figure  4.5: Monthly prevalence estimates of campylobacteriosis for a 16 county region in East Tennessee, 2003-2006.  
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Figure  4.6: Seasonal prevalence of campylobacteriosis for a 16 county region in East Tennessee, 2003-2006.   
(Error bars represent the 95% confidence interval)
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(95% CI: 0.73- 2.2) (Figure 4.6).  The only significant difference in the monthly 
prevalences was identified between the summer months (June, and July) and the month of 
April (Figure 4.7).  July had the highest average reported prevalence of 1.6 cases per 
100,000 (95% CI, 1.3-2.1) followed by June (1.1 cases per 100,000; 95% CI, 0.86-1.5) 
and August (1.1 cases per 100,000; 95% CI, 0.80-1.5).  April had the lowest average 
reported prevalence at 0.57 cases per 100,000 (95% CI, 0.37-0.85).   
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Figure 4.7: Average monthly prevalence of campylobacteriosis in a 16 county region in East Tennessee, 2003-2006.   
(Error bars represent the 95% confidence interval) 
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5.0 Discussion  
 The goal of this study was to perform a descriptive epidemiologic analysis of the 
cases of human campylobacteriosis reported in East Tennessee from January 2003 to 
December 2006.  Information resulting from the study may be used by health 
departments in East Tennessee to help enhance their strategies for disease control and 
prevention.  Generally, most of the epidemiologic characteristics of the 
campylobacteriosis cases observed in this study were similar to those in other studies 
conducted in the United States and around the world.  For instance, the highest 
prevalence occurred in young children under the age of 5 and during the summer months.  
These are patterns typical of campylobacteriosis in the developed world.  
 The error rate observed in the data used in this study varied greatly depending on 
the year, the type of error (inaccuracy or missing information) and the health department 
(KCHD or ETRHD).  Missing information or omissions in the computerized dataset, 
when information was present on the paper case report form, were classified as missing 
information errors since it can not be determined if the data was missing due to an 
oversight, a computer malfunction or purposeful omission.  The highest proportions of 
errors, from both health departments, were observed in 2004.  One reason for these high 
error rates could be a change in the database structure that occurred when a new data 
storage software application was adopted in 2004.  When this change occurred, 
differences in the field names in between the two different databases may have caused 
data to be deleted from some entries.  It is also possible that data could have shifted 
between entries, for example, the address for one patient was assigned to another patient 
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numerically ahead of that entry.  Since this change in database structure occurred during 
2004, only cases reported prior to the change were affected.  These issues suggest that 
there needs to be safeguards put in place to take care of potential data integrity issues 
during system upgrades and improvements in data structure. 
 Another problem observed in the data entry was that many patients were entered 
into the database as white or Caucasian when the race or ethnicity box on the case report 
form was left unchecked.  These patients were entered into the systems as “race = white” 
or “ethnicity = non-Hispanic”, when they should have been entered in as “race = 
unknown” or “ethnicity = unknown”.  This resulted in the high inaccuracy error rate 
observed in the race (10/79, 13%) and ethnicity (30/79, 38%) variables.  The “travel” 
variable had a high percentage of missing information errors (8/79, 10%).  The paper case 
report form indicated the patient had reported travel and this was not in the computer 
database.  Some of these errors were caused by the fact that the variable “travel” was 
added to the electronic database partway through the study.  It was introduced into the 
computer database during 2005, but due to the way the data is stored, all cases prior to 
the introduction date still had the travel variable present in their database entry, but it was 
blank. 
 The inaccuracy error rates observed in this study were similar to that reported for 
data quality in electronic medical databases[266, 267].  A study of a voluntary 
participation database of low birthweight infants in Vermont, found inaccuracy error rates 
between 1.3 - 8.8%[266].  That study analyzed ten variables for disagreement between 
the medical record and the computerized database.  Another study conducted in 
Pennsylvania analyzed the results of multiple published studies that reported the accuracy 
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of computer-based patient records (CPRs).  The inaccuracy error rate of the CPRs ranged 
from 0 to 64%[267], but most of the studies analyzed reported an inaccuracy error rate 
between 3-7%.  In this study the highest inaccuracy rate observed was 6.2% in the 2004 
Knox County dataset, and the overall inaccuracy rate for all datasets was 3%.  As with 
the missing data errors, the maximum and average percentages of inaccurate entries in the 
campylobacteriosis database in this study were within the range of inaccuracy errors of 
CPRs in the literature[267].  It was important for all the variables in the datasets used in 
this study to have complete and accurate information since they were used to create sub 
populations, to identify groups with a higher prevalence of campylobacteriosis.  
 Missing data error rates observed in this study were low (3.4%).  When missing 
data is expanded to included unknowns the percentage ranges from 0-52% (Table 4.2), 
these are similar to other descriptive studies of gastrointestinal illness using surveillance 
data[268, 269].  In published reports the percentage values that are unspecified or missing 
has a wide range.  A Canadian study of Salmonella serotype typhimurium reported 0-
99.8%[268] missing or unspecified values depending on the variable.  In that study, 
variables that had all data present were “Episode date” and “Disease”, while the variables 
with the highest percentage of missing data were “Hospitalization” (71.5%) and “Risk 
factor” (99.8%).  Another Canadian study of cryptosporidiosis reported a similar range of 
0-89.7%[269] of cases with missing or unspecified values.   In both Canadian studies the 
percentage of missing values was lower among the variables that were mandatory for 
reporting, especially demographic variables.  Of the mandatory variables in the Canadian 
studies, “Risk Setting” had the highest percentage of missing values (49.6%).  In the 
present study, the highest percentages of unknowns were observed for the variables 
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“Where was treatment sought” (52%) and Serotype (49%).   These variables were not 
required for reporting, while demographic variables such as age, sex, and race were, and 
as such had low (0-5%) percentages of unknowns.   
 The median age of patients in this study (26 years) was within the range of 
median ages reported by two Norwegian studies (22 and 29 years)[270, 271], but lower 
than median age of a 2000 case-control study in Quebec (median: 31 years, range: 11days 
– 91 years)[197] and a 1999 United States FoodNet case-control study (median: 34, 
range: <1-96)[198].  In the current study, the median age was significantly lower in the 
more rural counties. The study area (ET), on average, has more of the population 
classified as rural compared to the other FoodNet sites and this difference and the lower 
median age observed in the rural areas may have influenced the lower median age 
observed in this study compared to other US studies.    
 The percentage of cases under the age of 1 (9%) was much higher in ET than 
other published studies that reported 1.9% in New Zealand[19], and 3.5-4.0% in US[239] 
of cases under 1 year old.  In this study, the percentage of patients under 5 years old (24 
%) was also higher compared to those of other studies: 16.9% in Norway[270], 13.4-
13.8% in the US[239], 12.0% in New Zealand[19], and 11.5% in the United 
Kingdom[203].   A Polish study that analyzed the test results of all stool samples that 
were submitted for enteric disease isolation, found that 59% of the campylobacteriosis 
isolates were obtained from children under 2 years old[272].  That is much higher than 
the percentage observed in this study and may be due to differences in exposures or 
health care practices.  In countries where there is universal heath care, more adults may 
seek medical care for their symptoms than in counties without universal health care 
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which can affect the percentage of children in the study.  It is possible that the age 
differential observed in the US (more children seek medical care compared to adults) is 
more pronounced in Poland, or that children are exposed at a much higher rate in Poland 
so adult have some immunity and do not seek medical care.     
 The median age of patients from the most rural counties in ET was lower than that 
of the rest of the counties in this study (Table 4.3).  This is similar to the findings of a 
previous study that reported that more children were reported in the rural areas compared 
to the urban ones and the odds of infection increased in the more rural areas, especially 
for young children[245].  The lower median age in the rural counties could be due to the 
fact that young children in the more rural counties may be exposed to Campylobacter at a 
higher frequency than children in the more urban counties due to higher risk of animal 
exposure.  Moreover, the predominance of children in the rural areas of ET could be 
partially explained by the large percentage children in this study (>50% of children under 
1 year old) who drink privately owned well water that may not be appropriately 
disinfected. 
 On average patients in ET waited 3 to 4 days to seek medical care after the onset 
of their symptoms, 52% waited 3 days or less.  This delay may reduce the effectiveness 
of antibiotic treatment.  A meta-analysis of studies of the treatment of campylobacteriosis 
found that patients who waited 3 days or more to seek care reported the duration of 
diarrhea to be twice as long as patients who sought care less than 3 days after the onset of 
symptoms[86].  That study also reported that in 50% of the studies, the patients waited 
less than 3 days, while in the other 50% of the studies, the patients waited an average of 
6.5 days to seek care.  The reason for the longer delay in seeking care observed in 
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patients in ET may be due to the fact that patients in the US normally have to wait several 
days before they can be seen in a private physician’s office[273].  One survey of health 
care practices found that 50% of adults in the US had to wait for 2 or more days to see a 
physician[273].  Generally, most patients will wait for symptoms to warrant medical care 
(either in severity or duration), and then many will have to wait several additional days 
for an appointment to be seen by a physician.  These delays may prolong the duration of 
symptoms.   
 More patients in the present study (50%) visited an emergency room for their 
illness compared with patients in the FoodNet case-control study (37%)[198].  It is 
possible that the lower percentage of patients seen in the emergency room in the 7 states 
involved in the FoodNet study could be due differences in the physician to patient ratio or 
differences in the proportion of patients with health insurance between ET and the 
FoodNet sites.  The decision to seek medical care for their symptoms may be based on 
the patient’s socioeconomic status as well.  A US study of adult healthcare practices 
found that 57% of adults with “below average income” would choose not to visit a 
physician when ill due to the cost compared to only 12% of adults with “above average 
income”[274].  In Tennessee, there are programs for children to obtain health insurance 
through TennCare (the state healthcare provider) so more children may be seen by private 
practice physicians, since they have insurance, while those over 18 who do not have 
insurance may go to the emergency room to seek medical care.  The percentage of 
patients seen in a physician’s office, in this study, was higher for patients under 18 years 
of age (55%) than those over 18 (45%) but this difference was not statistically significant.  
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 Most (99.5%) of the cases of campylobacteriosis in ET were diagnosed from a 
stool sample and the rest (0.5%) were identified from a blood sample; this percentage is 
identical to that observed in the FoodNet case-control study in 1998-1999[198].  The 
descriptive FoodNet study from 1996-1999 found similar results, 99% of samples were 
from stool and 1% were from blood[239].  Approximately half of the Campylobacter 
isolates in the present study were sent to the state laboratory for speciation.  The 
percentages of each Campylobacter species observed in this study (C. jejuni: 98.6%, C. 
coli: 0.9%, dual infection: 0.4%) are similar to those observed in 7 states of the United 
States in 1998-1999.  That FoodNet case-control study of 1316 patients, reported 95% C. 
jejuni, 4% C. coli, 1% C. lari, and 1 case of C. mucosalis[198].  In a Norwegian study, 
92% of the 212 cases were infected with C. jejuni  while the remaining 8% were infected 
with C. coli[271].  A study of 285 cases in France found 81.7% infected with C. jejuni, 
15.3% with C. coli, 1.3% with C. fetus, and 1.7% with C. lari[275].   The lower isolation 
rate of C. coli (commonly identified in pigs) observed in the current study may be due to 
either fewer isolates being sent to the laboratory for species determination, or a lower 
prevalence of the bacteria in the region.  The lack of C. lari and C. upsaliensis (reservoirs 
unknown) isolation in ET may be due to its low prevalence in the region or the growth 
inhibition of C. upsaliensis by the antibiotics used in the standard stool culture 
media[41].  
 Diarrhea is considered a hallmark symptom of campylobacteriosis, 97.5% of 
patients in ET who provided clinical information reported experiencing diarrhea.  This is 
similar to other descriptive studies.  A smaller study conducted in Denver, CO in 1979 
reported 100% [117], a report from England and Wales observed 96% [276], and a 
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French study reported 96.5%[275] of patients experienced diarrhea.  On the contrary, 
volunteers who were experimentally infected with C. jejuni all had positive stool cultures, 
indicating infection, but only 46% experienced diarrhea[76].     
 Just over a third of the patients in this study reported bloody diarrhea.  This may 
be under-reported since some patients may not have examined their stool closely and may 
have missed seeing blood.  This percentage is lower than other reports from the United 
States but similar to other worldwide reports and the results of experimental infections.  
In the FoodNet case-control study, 45% of patients reported bloody diarrhea[198], while 
a 1978 US study reported 42%[117].  Human experimental infections, conducted in 
Maryland, found that of volunteers with positive stool cultures, 36% experienced bloody 
diarrhea[76].  Worldwide, bloody diarrhea was reported by 35.2% of patients in New 
Zealand [199], 28% in England and Wales[276], 45% in Iran[277], 22% in Yemen[278], 
10% in Bangladesh[279] and 15% in Thailand[280].  The percentage of patients who 
experience bloody diarrhea may depend on the virulence of the strain or species of 
Campylobacter and the immune status of the patient[281].  If the bacteria are able to 
damage the intestinal epithelial cells sufficiently by invasion or toxins, bleeding may 
occur.  
 The majority of patients in ET also reported fever (62.5%), and cramps (56.2%); 
only 37.5% of patients reported experiencing both.  These symptoms were observed at a 
lower rate than the FoodNet case-control study in which over 80% of patients reported 
fever and cramps[198] and a smaller 1978 study of 35 patients where 96.6% experienced 
“abdominal pain” and 91% experienced fever[117].  Among studies conducted in other 
industrialized countries, these symptoms were also reported more frequently than the 
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findings of the current study[19, 276].  In a study conducted in Yemen, a lower 
percentage (21%) of patients reported fever but “abdominal cramps” were reported by a 
higher percentage (86.6%) when compared to patients in ET.  Since symptoms in this 
study were self reported, differences in interviewer phrasing, interpretation of the 
responses or degree of emphasis of the questions could have influenced the response of 
the patient.  One reason for the lower percentage of patients reporting cramps, in this 
study, may be the large proportion of children under 5 in the study dataset.  These 
children may be unable to understand what the symptom is or be able to communicate the 
source of their discomfort to their parents who were interviewed for this information.   
 Associations between clinical symptoms in the present study were examined to 
determine if symptoms were commonly reported in combination, which may indicate 
similar strains of Campylobacter spp.  A quarter of the patients reported nausea and 
vomiting together; this is logical since nausea is the conscious recognition of the 
subconscious excitation of the medulla associated with the vomiting center[179].  Also 
associated were the reporting of nausea with cramps, headache with fatigue and headache 
with muscle aches.  None of these associations of symptoms formed temporal or spatial 
clusters that would indicate that the cases may have been associated or from the same 
strain.   
 Interviewer phrasing may have also influenced the percentage of patients 
reporting chills.  In 2006, the symptom “chills” was added to the new campylobacteriosis 
case report form as a possible symptom in the form of a check box.  After the new case 
report form was implemented, the interviewer specifically mentions chills, while prior to 
this time chills was only reported if the patient initiated the response when questioned for 
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“other”.  After this change in the case report form, the percentage of patients who 
reported chills dramatically increased.  During the first 3 years of the study (2003-2005), 
1.0% to 6.4% of patients reported experiencing chills, however in 2006 this percentage 
jumped to 22.4%.  This increase was not likely due a true increase in percentage of 
patients experiencing chills, but more likely due to its inclusion on the symptom list on 
the case report form, about which patients are questioned. 
 There was an association between some symptoms of campylobacteriosis and the 
age of the patient, in this study.  These associations were investigated to see if there was a 
pattern of symptoms being reported by patients in different age groups, since previous 
studies reported an association between age and bloody stool.  Patients in the youngest 
age group (under 5) were more likely to report bloody diarrhea than those in the older age 
groups (Table 4.7).  A similar observation was made in France where 54.8% of children 
15 and under reported bloody diarrhea while only 35.1% of patients over the age of 15 
reported it [275].  A study in Thailand also reported a similar result; 30% of children 
under 5 years old experienced bloody stool while only 15% of all ages experienced 
it[280, 282].  It has been hypothesized that this age related difference in the occurrence of 
bloody diarrhea, could be due to the infection being the first exposure to Campylobacter 
among young children which cause bloody diarrhea[283].   
 While a statistical association between age group and non-visible symptoms of 
campylobacteriosis exists, it may have no clinical relevance.  These include the non-
visible symptoms of nausea, cramps, muscle aches, headache and fatigue where is no 
physical evidence of the symptom.  Since the parents may not recognize these symptoms 
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in their young child if the child could not communicate these symptoms to their parent, 
one or more of these symptoms may have been present but not reported. 
 The duration of symptoms varied widely among the patients in ET (range: 1 day-
180 days).  The patient that reported 180 days also reported experiencing gastrointestinal 
symptoms for several months before seeking medical care and may have attributed 
previous symptoms to their campylobacteriosis diagnosis.  The median duration of 
disease (7 days) experienced by patients in this study is similar to reports from the US 
and other industrialized countries.  In the FoodNet case-control study of 1999 the median 
duration was 6 days, (range: 1-31 days)[198].  The CDC reports that most cases recover 
completely in 2-5 days, but sometimes recovery can take up to 10 days[284].   A smaller 
study in Colorado reported that 80% of patients experienced a duration of illness of 1 
week or less[117].    A 1982 study in West Germany found the average duration of 
diarrhea to be between 2 and 7 days[285].  The median duration of disease was also 7 
days, but with a much shorter range(1-16 days) in New Zealand[199], while the range 
was much longer (0-701 days) in England and Wales where an average of 10.7 days of 
illness per patient was reported[276].  Reducing the duration of disease can have 
substantial effect on the cost of campylobacteriosis by reducing hospitalizations costs and 
lost wages. 
 When classified by the severity of disease index, almost half (48%) of the patients 
in this study experienced mild disease and less than 10% experienced severe disease.  
The scale was used to provide a method to classify patients according to their severity of 
disease and possibly identify population groups who experience more severe disease, 
however none were identified.  One disadvantage of the severity of disease scale is that it 
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is heavily dependent on symptoms of disease, many of which are not visibly identifiable 
in young children such as: muscle aches, fatigue or cramps.  The highest severity score 
for a child under 5 years old was 13.  That child was 4 years old and may have been able 
to communicate more of the signs of illness to their parents; that child reported fatigue, 
cramps ad nausea.  If the children in the youngest age group (under 5) are removed from 
the mean calculation, the mean severity score increases from 7.6 to 8.1±3.  This increase 
may not necessarily indicate that adults experience more severe disease than children, but 
may be due to the fact that they are able to report symptoms themselves.  A better 
severity of disease scale could have two possible values, one for adults and children over 
5, and a different value for children under 5.     
 The following recommendation for the treatment of campylobacteriosis is found 
at the CDC website:  
“Almost all persons infected with Campylobacter recover without any 
specific treatment. Patients should drink extra fluids as long as the 
diarrhea lasts. In more severe cases, antibiotics such as erythromycin or a 
fluoroquinolone can be used, and can shorten the duration of symptoms if 
given early in the illness. Your doctor will decide whether antibiotics are 
necessary.”[284] 
 
The majority (84%) of patients in this study received at least one antibiotic.  The most 
common antibiotics prescribed were fluoroquinolones and macrolides which are in line 
with the CDC’s recommendations.  No information on antibiotic sensitivity testing of the 
Campylobacter isolates was collected in this study, but sensitivity testing may become 
more common since antibiotic resistant Campylobacter are becoming more 
prevalent[286].     
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 The percentage of isolates that are fluoroquinolone resistant is increasing 
worldwide, especially in developing countries[82].  In my travels in developing countries, 
I noticed it was common practice to take a single antibiotic pill, instead of a full course of 
several days of treatment, to treat minor infections and other illnesses such as a cold.  
Such practices may play a role in the higher Campylobacter resistance rates in these 
countries.  This is also important since many adults in developing countries can be 
asymptomatically infected with Campylobacter.  Due to the high level of Campylobacter 
resistance to fluoroquinolones outside the United States (84% in Thailand[287] and 72% 
in Spain[140]), doctors should consider travel history and exercise caution when 
prescribing fluoroquinolones to those who have traveled internationally[146].  It is 
important since some studies have shown that treating fluoroquinolone-resistant 
campylobacteriosis with a fluoroquinolone causes more severe disease[144]. 
 The youngest age group (under 5) had the lowest percentage of patients who 
reported receiving an antibiotic (77%) while 100% of patients in the 65 and over age 
group received at least one antibiotic.  The higher percentage of patients receiving an 
antibiotic in the oldest age group may be due to concerns of the physician that older 
patients may have other medical conditions that could increase the risk of complications 
if the infection is not treated aggressively[288].  The lower frequency of antibiotic 
treatment among young children may be due to fears of antibiotic complications[135].  In 
young children there is an increased risk of hemolytic uremic syndrome (HUS) if infected 
with E. coli O157:H7 which is the most common cause of bloody diarrhea in 
children[135].  Due to the risk of complications, antibiotics should not be prescribed to 
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children before the etiologic agent can be confirmed and a confirmatory diagnosis 
made[48].   
 Similar percentages of infants under age 1 were treated with antibiotics in ET 
(72%) and other FoodNet sites (72%) [14]; however the percentage for children under 
age 1 year old and  5 years (77%) were much higher than other countries.   A Swedish 
case-control study of children under 6 reported that only 13.4% were prescribed an 
antibiotic[204].  This difference could be due to differences in the specific policy and 
treatment guidelines of the national public health agency of each country.  In the US, the 
CDC recommends that an antibiotic could shorten duration and a doctor will decide if 
one is necessary.   While the Swedish Society for Communicable Disease Prevention and 
Control and The Swedish Institute for Infectious Disease Control both state that the 
infection generally clears up on its own with oral rehydration and antibiotics are only 
given in rare cases[289, 290].  The emphasis of the Swedish recommendations is against 
the empiric treatment with antibiotics and this may be the reason why fewer children 
received them. 
 On average, 23% of the campylobacteriosis patients in this study were 
hospitalized each year during 2003-2006.  This is higher than that reported in the 
descriptive FoodNet study of 12,707 patients from 1996 to 1999 (10%)[239],  the 
FoodNet case-control study of 1316 patients in 1998-1999 (12%)[198] and a 2001 report 
of 286 patients in the Denver metropolitan area (9.8%)[291].  The percentage of 
hospitalizations in ET is also much higher than in other countries: reported percentages of 
hospitalizations are 3% in Ontario, Canada[292], 4.9 % in New Zealand[19], 10.2% in 
England and Wales[276], and 10.8% in Denmark[293].  In the present study, some (30%) 
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patients spent 1 day or less in the hospital, if these patients are removed, the proportion of 
patients hospitalized (LOS >1, 16.5%) was also higher than expected. Of the states 
participating in the descriptive FoodNet study, Georgia had the highest percentage of 
cases hospitalized at 15.2%[239].  Georgia borders part of Tennessee to the South and the 
percentage observed there is closer to that observed in ET.  The higher than expected 
percentage of hospitalizations among the older patients (65 and up) may have led to a 
higher than expected overall percentage hospitalizations. 
 The observed high hospitalization percentage (60%) among the 65 and older age 
group of patients in this study was much higher than the overall percentage (23%) for all 
ages.  This difference could be due to complications from other health conditions that are 
more common in older patients.  The hospitalization proportion observed in the oldest 
patients (65 and up: 60%, 60 and up: 56.3%) was also much higher than that reported in 
the 1996-1999 FoodNet study (26.8% of patients 60 and older)[239] and a New Zealand 
study (9.6% of patients 60 and older)[19].  The lower percentage of hospitalization of 
older patients observed in New Zealand may be due to differences between the health 
care systems of the two countries.  In New Zealand, on average, patients are seen by a 
doctor sooner, may be treated sooner, may not develop as severe of disease and therefore 
may not need to be hospitalized.  In a study of worldwide healthcare practices, 58% of 
adults in New Zealand were seen by a doctor the same day and 81% were seen by the 
next day compared to the US where only 30% are seen on the same day and 47% by the 
next day[273].   
 The under 5 age group had the lowest percentage of patients hospitalized (11.5%).  
This may be due to the fact that parents take their younger children to the doctor at the 
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first sign of illness and the child is then treated early on in the course of disease thus 
reducing the need for hospitalization.  One theory for the higher hospitalization 
percentage in the 5-14 age group (27.3%) was that older children may wait longer to seek 
medical care resulting in a higher hospitalization percentages, however this was not 
validated in this study as the median delay in seeking care was 3 days for both age 
groups.   
 Although, patients in the present study were hospitalized more often than the rest 
of the country and other parts of the world, the length of stay (LOS) was on average 
shorter for patients in this study (median: 2 days, range: <1 to 11 days).  In the FoodNet 
study using data collected from 1996-1999 the mean LOS was 4.6 days and 8% of the 
cases that were hospitalized spent more than one week in the hospital[239].  Only 4 of the 
101 (4%) hospitalized patients in ET remained in the hospital for 7 days or more.  A 
Denver 2001 report also observed that 4% of patients had a LOS greater than 7 
days[291].  The mean LOS was longer (3.9 days) in England and Wales[276].  It is 
possible that the patients who were hospitalized in this study were less severely affected 
as patients who were hospitalized in other states and countries and therefore did not 
require as long of stay in the hospital.  Patients in this study who were hospitalized had a 
higher severity score than those who were not.   
 The highest percentage of hospitalizations (28.4%) occurred in the summer, and 
the fewest in the winter (19.8%).  This difference may be due to a greater seasonal 
potential for exposure due to differences in behaviors, such as more outdoor activities and 
more travel.  During the summer, due to the hot weather, more recreational water 
activities occur, in rivers and lakes, such as fishing, boating, and swimming.  Also more 
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outdoor barbecues occur during the warmer months; during these events there is a higher 
risk of consumption of undercooked meat and cross contamination of food which could 
lead to a larger inoculum of the bacteria from the undercooked food.  The seasonal 
differences in the hospitalization percentages observed in this study are unlike those 
described in New Zealand where the percentage of cases hospitalized remained almost 
constant between 4.7 and 5.0 percent in each season[19].  Although the seasons are 
reversed in New Zealand and the climate of the entire country is not exactly the same as 
ET, there are still large temperature differences between the seasons, similar to the 
temperature changes observed in ET.    
 During the 4 year study period, only 1 (0.3%) patient died.  A 4 year FoodNet 
study of 5 sites reported that 11 patients died as a result of their illness[239].  The average 
annual campylobacteriosis specific mortality risk (number of deaths due to 
campylobacteriosis/total study population) was 0.096 deaths per 100,000 in ET and 0.074 
per 100,000 in the FoodNet sites.  While the campylobacteriosis specific mortality risk 
was higher in ET, this difference was not statistically significant, since both estimates 
have wide confidence intervals due to the low number of total deaths.  
 Contact with animals in the 10 days prior to the onset of symptoms was the most 
commonly reported risk factor in this study.  This is an important health concern since 
Campylobacter is a zoonotic agent that can infect both animals and humans, and animals 
can be asymptomatically infected. One report warns that exposure to a dog with diarrhea 
triples a person’s risk for campylobacteriosis[294].  Due to the increase in the number of 
stools for a dog with diarrhea, there may be a higher risk of fecal exposure, but studies 
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have shown that dogs with and without diarrhea are equally likely to carry 
Campylobacter[35, 295, 296]. 
 Dogs (74%) and cats (33%) were the two most commonly reported animals that 
patients were exposed to in this study.  Depending on the location and clinical conditions 
of the animals sampled and the Campylobacter species isolated, infection rates have been 
reported at  27.9%[297], 15-26% [298], and 51.1-87%[299] in dogs and 16.8% [300] and 
24% [36] in cats. Cats have been found to be infected with C. upsaliensis more frequently 
than C. jejuni or C. coli; however this species is not frequently identified in humans.  The 
lack of identification in humans could be due to growth inhibition of C. upsaliensis by the 
antibiotics used in the standard stool culture median used in the isolation of 
Campylobacter spp.  In spite of this, cats still remain an important health concern of 
zoonotic campylobacteriosis.  Almost 10% of patients reporting animal exposure came in 
contact with live chickens.  Poultry are an important reservoir of Campylobacter.  At a 
live poultry market in New York, 83% of the chickens were positive for 
Campylobacter[301] and 27% of broilers were positive at a farm in England[302].  Daily 
contact with poultry had borderline significance as a risk factor for campylobacteriosis in 
a case-control study in Denmark (OR:2.11, 95% CI: 0.99-4.49), but daily contact with a 
cat with diarrhea (OR:3.77, 95% CI: 1.03-13.83) or a cow (OR:3.09, 95% CI: 1.09-8.74) 
were found to be significantly associated with disease[13]. 
 Children in this study under 5 years old were more than 3 times more likely than 
those over 50 to report animal exposure; this is most likely due to difference in behaviors 
of these age groups.  One reason may be that children are more likely to have a family 
pet, visit friends with pets or go on a school trip that could put than in contact with 
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animals compared to older adults. Also children are less likely to wash their hands after 
handling animals, while older adults most likely will.  One case-control of children in 
Sweden found the odds ratio for reporting dog exposure to be higher for children under 2 
years (9.1, 95% CI:3.7-27.0) compared to the odds ratio for children aged 2-6 (2.4, 95% 
CI:1.1-5.1)[204].  While the present study did not include controls, the pattern observed 
in the Swedish study is similar to the pattern observed in this study, that children had the 
highest animal exposure. 
 Of all the animal exposures recorded in this study, it was not noted if the contact 
occurred in a work or recreational environment.  The type of contact could change the 
amount of exposure that occurs.  Another study defined contact with an animal as 
“handling or touching the animal or its excrements”[202].  No definition was used in this 
study, so it is possible that some patients, who reported contact, may not have been 
classified as exposed if the previous definition is used.  A more thorough definition might 
include a quantification of the amount, duration, and type of exposure to the animal (in 
the same room as an animal, just hand contact, had animal on lap, facial contact with the 
animal, contact with animal excrement, if the animal sleeps on the bed).  Since the 
animals in question were not tested for campylobacteriosis as well, it can not be assumed 
that the human infection was caused by to the animal exposure. 
 Travel outside the state or country was the next most commonly reported risk 
factor (21.6%).  The percentage of patients in this study who reported international travel 
(11.3%) is similar to that of the FoodNet case-control study (13%).  More patients in ET 
traveled to Central and South America (23%) compared to patients in the FoodNet study 
(10%) but fewer traveled to Europe.  The difference in destination between the two 
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studies may be due to type of travel (business, pleasure or altruistic) or differences in the 
socioeconomic class of the populations.  Several cases in ET noted that they contracted 
campylobacteriosis while on church mission trips, some of which were to Central and 
South American countries.  Altruistic trips, such as church mission trips, are often made 
to the more rural parts of developing countries, where the risk of exposure is greater.  
These trips may be an important source of exposure and a factor in the prevalence of 
campylobacteriosis in the region and in the rest of the US. 
 A French case-control study found that 5.6% of the cases and only 2.4% of the 
controls reported international travel in the 8 days prior to the onset of symptoms, which 
was a borderline significant a risk factor (OR=2.5, 95% CI: 0.9-6.4)[275].  None of the 
patients in that study visited Central or South America.  The percentage of international 
travel observed in that study is lower than that observed in the present study.  This may 
be due to the destinations of the patients in the French study being less rural compared to 
those in this study.  In Denmark, travel was identified as a risk factor in a 1996-1997 
case-control study.  In that study, travel was reported by 18.4% of the cases and only 
9.4% of the controls[13].  The percentage of patients reporting international travel is 
much higher in Denmark where most cases had a history of travel to “Southern Europe, 
the Middle East or Asia.”  Since that study did not differentiate the percentages of 
patients traveling to each location, it can not be compared to the locations in the present 
study.  The present study is also very different from a Norwegian study which reported 
that 53% of 12,327 cases that occurred between 1995 and 2001 were acquired abroad. 
 The differences in travel patterns observed among the various age groups (Table 
4.13) may be related to behavioral patterns of the age groups.  Many adolescents and 
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young adults in the 15-29 age group report international travel since many college 
students spend semesters abroad and members of this age group may be able to travel 
more due to more disposable income and many do not have children yet.  Members of the 
65 and over age group are past retirement age and therefore may have more time for 
travel, however the most of the patients in this study traveled locally, within the United 
States. 
 The odds of reporting any travel were 2.8 - 5.0 times higher for patients in the 
urban counties than those in the more rural counties.  This may be due to differences in 
socioeconomic class; people in the more urban counties may be able to afford more 
travel.  This is especially true for international travel, none of the patients in the least 
urban counties traveled internationally, while 59.6% of patients in the most urban did.  It 
is possible that more patients in the urban counties had jobs that required international 
travel, or a higher income compared to patients in rural counties.  There was also an 
association between the prevalence group of a county and travel; patients from counties 
with a lower prevalence were more likely to report travel.  This result could be influenced 
by the urbanicity of the counties since the counties in the highest prevalence group were 
also some of the most rural counties. 
 Handling raw meat or poultry was reported by 21.6% of the cases in East 
Tennessee.  This is lower than observed in the FoodNet case-control study where 48% of 
patients reported preparing raw chicken and 27% of patients reported touching raw 
chicken[198].  It is possible that some of the difference in the percentages between this 
study and the FoodNet study observed is due to differences in the phrases “prepare” and 
“handle”.  There was a large difference in the FoodNet study, with more patients 
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reporting preparing than handling.  It is possible that in this study someone may have 
reported preparing raw chicken, but not handling it which could explain the lower 
percentage observed for raw meat exposure.  No information was provided in the 
FoodNet report on exposure to meat other than chicken.  The percentage of patients who 
reported handling raw meat in East Tennessee is similar to that observed in France where 
19.4% of patients prepared meat or poultry[275].  A case-control study in Norway found 
preparing raw poultry to be a significant risk factor for disease, 20% of the cases reported 
it, while only 2% of the controls did (OR: 9.55, 95% CI: 2.09-43.69)[202].  Due to the 
high level of Campylobacter contamination that has been reported in some retail poultry 
products, (81% of 525 chickens sampled in a Consumer Reports study[71]), care should 
be taken to avoid direct exposure from raw meat, through thorough hand washing.  A 
Swedish case-control study observed that 16% of campylobacteriosis cases did not clean 
their hands during food preparation compared to only 10% of controls[208].  Another 
case-control study in Seattle, WA found that cases were less thorough than controls in 
cleaning meat cutting surfaces or using separate cutting surfaces[303].  Cutting surfaces 
should be thoroughly cleaned and separate surfaces should used for meat and produce.  
Meat should also stored on the lowest shelf in a sealed container to avoid cross 
contamination of other foods.          
 Reporting the risk factor “handling raw meat or poultry” was significantly 
associated with the sex of the patients with females having 1.5 times higher odds of 
reporting handling raw meat or poultry, when compared with males.  This difference may 
be due to cultural and behavioral differences between the sexes; women are more likely 
to prepare meals at home.  There was also an association between handling raw meat and 
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age; with members of the 30-49 age group reporting the highest percentage of raw meat 
handling (37.1%).  Members of this age group had 12 times higher odds of reporting 
handling raw meat or poultry when compared to patients in the under 5 age group (4.4%).  
This difference could be due to behavioral factors since young children (under 5 years) 
rarely help in the preparation of the meal and when they do, it usually does not involve 
handling raw meat. 
 Swimming in water from natural sources has been shown to be associated with 
the acquisition of campylobacteriosis[207], and other recreational water use such as 
fishing or boating may pose a similar risk.  Recreational water has also been associated 
with an outbreak of waterborne gastrointestinal illness caused by Cryptosporidium in ET.  
That outbreak occurred at a “splash pad” (an interactive fountain where children play in 
the water that comes up as jets from the ground) during the summer of 2006[304].  
Recreational water exposure was included by the health department on the 
campylobacteriosis case report form under the risk factor variable “hike, camp, swim or 
fish”.  For this risk factor there was no distinction made between the type of water or 
which of 4 activities took place or if water was ingested.  In ET 19% of patients reported 
at least one of the 4 activities in the 10 days prior to the onset of symptoms.  This risk 
factor was found to be associated with the season in this study.  During summer and 
spring 26.2% and 25.4% of patients, respectively, reported at least one of the 4 activities 
compared to only 13.5% in the fall and 7.1% in the winter.  These differences are likely 
due to the climate of the area, very hot summers and cool winters, so participation in 
these activities is more likely to occur in the warmer months.  
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 Due to the potential for fecal contamination, drinking untreated water is 
considered a high risk behavior for exposure to Campylobacter[65, 67].  In East 
Tennessee 10% of cases reported drinking untreated water from a stream, spring or other 
untreated source in the 10 days prior to the onset of symptoms.  In the FoodNet case-
control study, drinking untreated water from a lake, river or stream was identified as a 
risk factor in the univariate analysis; 4% of cases had engaged in this behavior compared 
to just 2% of controls (OR: 2.9, 95% CI: 1.6-5.3)[198].  Both of these percentages are 
much lower than the percentage of patients who drank untreated water in this study.  The 
percentage of patients who drank untreated water may be higher in ET than other US 
sites because this type of water source and the practice of drinking untreated water may 
be more common in the rural areas of ET than the population of the FoodNet study that is 
more urban, on average.  Patients who reported drinking untreated water were also likely 
to report hiking, camping, fishing or swimming, with 7% of all patients reporting both 
(OR: 13.5, 95% CI: 6.5-28.0).  The wording on the case report form changed in 2006 
from “Drink from a spring, stream or lake?” to “Did the patient drink untreated water?”  
This change could have resulted in a higher or lower percentage of patients reporting this 
risk factor so drinking untreated water cannot be analyzed across the years of the study.   
 Drinking well water has been identified as a risk factor for infection in case-
control studies involving all ages in Finland[207] in children in Sweden[204], and in 
infants in the US[14].  In ET, 31.3% of patients reported that their household drinking 
water source was a private well and 3% reported it was a spring.  Both of these sources 
can become contaminated if not properly protected.  Information was not collected on the 
specific characteristics of each well or spring in this study; some patients noted that the 
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well had been tested and treated, while others stated they had never treated their well.  No 
standardized data collection was performed regarding the timing or type of well testing or 
treatment.  Drinking well water was especially common in young children, 40.2% of 
children under age 5 and 51.6% of children under age 1 had a well as their drinking water 
source.  These percentages are much higher (p=0.0012) than those observed in the infant 
(<1 year of age) FoodNet case-control study where only 22% of cases and 8% of controls 
used well water[14].  The higher observed percentage of well water reported in this study 
may be due to an increased number of patients in the study from rural areas when 
compared to the average of the FoodNet sites.  Adults in the rural areas with household 
well water may have developed immunity from past drinking water exposure and are 
therefore a lower proportion of the rural adults may develop campylobacteriosis 
symptoms.  Immunity amongst the rural adults could also explain why there is a high 
percentage of young children in the rural areas who drank well water.  The Swedish case-
control study of children also reported a difference in the percentage of cases on well 
water based on age, 34% of children under 2 lived in a home with a well compared with 
26% of children aged 2-6 years old[204].  While the percentages are still lower than those 
was observed in this study, the same age pattern was reported.  Not every well can be 
considered the cause of the Campylobacter infection, however periodic monitoring and 
appropriate treatment of wells is important in reducing the prevalence of 
campylobacteriosis. 
 Contact with another person with similar symptoms was reported by 14.7% of the 
patients in this study, but most of the symptomatic contacts did not seek medical care so 
an exact diagnosis was not obtained.  The type of contact that occurred was also not 
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identified so it is not known if the contact was a potential source of infection, if there was 
a common exposure or if the other person was even infected with Campylobacter, 
although it possible that contact with another infected individual may not have been the 
actual source of infection as well.  In the FoodNet case-control study, 7% of cases 
reported a household member with diarrhea in the 4 weeks before illness compared to 
11% of controls[198].  In that study, having a household member with similar symptoms 
was identified among the controls as a protective factor since the control patient may 
have been exposed previously and may have developed immunity but were not 
symptomatic during the earlier infection.   
 Due to the possibility of fecal exposure, contact with dirty diapers has been 
associated with transmission of campylobacteriosis, and therefore childcare or daycare 
centers could be important sources of its spread[305].  In ET, 8.4% of cases reported the 
risk factor “household member in daycare” (inclusive of the patient).  The FoodNet case-
control study of infants, reported that attending childcare was not significantly associated 
with campylobacteriosis in the multivariable analysis[14].  In this study, having a 
household member in daycare was associated with age; the 3 age groups with the highest 
percentages were: under 5 (13.5%), 30-49 (12.9%) and 5-14 (8.5%).  The 15-29 (3.3%), 
65 and over (2.9%), and 50-64 (0%) age groups had lowest percentages.   This 
association may be due to differences in family structure, the 30-49 year olds may have 
children of the age that could be in daycare, while the children under age 14 could have 
siblings that are.  Although it was not identified as a significant risk factor in previous 
case-control studies, several outbreaks of campylobacteriosis have occurred at daycare 
centers[225].  
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 The average annual prevalence of campylobacteriosis over the 4 year study period 
in East Tennessee was 10.4 cases per 100,000 population.  This is significantly lower 
than that of the entire FoodNet region (12.7 cases/100,000 population) and significantly 
higher than that of the state of Tennessee (7.4 cases/100,000 population).  It is possible 
that these prevalence estimates reflect the true prevalence of disease in ET, Tennessee 
and around the US.  There are also numerous factors that could influence disease 
reporting and the reported prevalence, which may be responsible for a portion of the 
observed differences in the prevalence of campylobacteriosis.  Some parts of the state or 
country may have different or better reporting practices by the laboratories involved 
despite the active surveillance conducted by the health departments.  This may result in a 
higher percentage of the cases identified in the laboratories and a higher percentage 
reported to the health department.  Another possible factor is that doctors in some areas 
may be more likely to request a stool sample/culture from their patients which could lead 
to a higher percentage of cases identified in those regions.  Worldwide a higher 
percentage of children seek medical care for their symptoms than adults, but it is possible 
that this difference may be more pronounced in some areas compared to others.  Another 
factor that could influence the decision to seek care (and disease reporting) is access to 
medical care.  In some states there is better state insurance and a difference in the 
percentage of the population that has private insurance exists.  The areas with a higher 
percentage of the population insured may have a higher reported prevalence of 
campylobacteriosis since more patients are seeking medical care and therefore more are 
entered in the reporting database.  In this study, the majority of patients were classified as 
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white (>95%), so comparisons across race and ethnicity could not be made due to the 
small sample size of the other races. 
 The patterns of age- and sex-specific prevalence estimates observed in this study 
are similar to those reported in previous studies.  Children under 5 years of age had the 
highest prevalence of campylobacteriosis (41.6 cases per 100,000).  This is significantly 
higher (p=0.0051) than reported in 1999 of 7 FoodNet sites which found a prevalence of 
30.9 cases per 100,000[239].  While the prevalence of disease among children under 5 
was higher in ET than the rest of the US, it was lower than that reported in Ontario, 
Canada (52.5 cases per 100,000)[292], the Eastern Townships of Quebec, Canada (169.2 
per 100,000)[197] and Manitoba, Canada (males: 53.6 per 100,000, females:40.4 per 
100,000)[244].   Although a bimodal age distribution has been reported in other studies in 
the US[239] and worldwide[4, 19, 292], a second peak (prevalence above the average) 
was not observed in the young adult population (ages 15-29) in the present study.  Some 
authors have hypothesized that the second peak may be due to a higher proportion of 
young adults traveling to other countries where they may be exposed to Campylobacter.  
The lack of the second peak in ET may be due to a relative lower proportion of travel 
reported by young adults compared to other areas where the peak was observed. 
 The higher prevalence in young children in ET compared with other FoodNet 
sites may be due to differences in the age at first exposure.  On average, ET is more rural 
than the other FoodNet sites and therefore children may be exposed to and infected with 
Campylobacter at a younger age in ET since there may be greater chance of exposure in 
the rural areas where animals, especially farm animals are more common.  This is 
compared to more urban areas where a larger percentage of the population may not be 
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exposed until later in life.  This hypothesis is supported by the findings of a study in 
Manitoba, Canada which reported that the incidence of campylobacteriosis was much 
higher among young children in the rural areas(males: 97.5 per 100,000, females: 72.8 
per 100,000), compared to the urban ones(males: 13.2 per 100,000, females:10.5 per 
100,000)[244].  In the urban areas of that study, the highest incidence was observed in the 
20-24 year olds.  Worldwide the highest prevalence estimates have been observed in 
young children.  Some of the high reported prevalence estimates may be due to the lower 
inocula needed to infect an infant.  Young children also often place foreign objects in 
toys in their mouths; this behavior could also lead to more young children becoming 
infected.  Another reason for the high prevalence in young children may be due to a 
greater proportion of young children seeking medical care.  Parents are more concerned 
when their 1-year-old is sick than when they (the parents) themselves are sick[233]. 
 Grainger County had the highest age- and sex-standardized average annual 
prevalence of campylobacteriosis at 22.9 cases per 100,000 population.  This prevalence 
is twice the average for the study region, and three times the average prevalence of the 
state of Tennessee.  Several other counties had standardized prevalence proportions that 
were higher than the average prevalence of the study region.  Jefferson County (21.8 
cases/100,000 population) borders Grainger County to the South and Union County (14 
cases/100,000 population) borders Grainger County to the West, these three counties 
could be grouped to form a group of high risk counties.  These three high risk/prevalence 
counties are all rural areas (<25% urbanicity) which may explain the observed, above 
average prevalence proportions reported in these 3 counties.  A similar pattern was 
observed in Manitoba, Canada where researchers reported that the prevalence of 
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campylobacteriosis was higher in almost every age group in the rural areas compared to 
the urban ones in the city of Winnipeg[244].   
 The standardized prevalence proportions were also above the average in Blount 
(15.6 cases/100,000 population) and Loudon (13.1 cases/100,000 population) Counties.  
Unlike Grainger, Jefferson, and Union counties, Blount and Loudon counties both fall 
into the 2nd urbanicity group (44-66% urban) since 63.2 and 50% of the populations live 
in an urban area, respectively.  The reason for this finding is unknown.  Geographically, 
in between these two areas (Grainger, Jefferson and Union, and Blount and Loudon 
counties) of above average prevalence is the most populous county, Knox County.  
Although Knox County is 87% urban and some studies have identified an association 
between urban dwellings and high prevalence of disease[239], the standardized 
prevalence in Knox County was only slightly above average at 11.8 cases per 100,000 
population. The age- and sex-standardized prevalence estimates shown in Figure 4.2 for 
each CCD show how the areas of high prevalence extend across the county lines.  The 
map shows that the area of high prevalence in Grainger and Jefferson counties is 
clustered toward the Western ends of the counties and this area of high prevalence 
crosses into Eastern Knox County.  While some of the areas of the map are white, this 
does not indicate that campylobacteriosis is not occurring in these areas; just no cases 
were reported to the health departments from those areas.  The prevalence estimates also 
show the areas of higher prevalence within each county that can be useful in health 
planning. 
 It appears that the reported prevalence of campylobacteriosis is decreasing in East 
Tennessee while it remains steady in the state of Tennessee and the rest of the US 
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FoodNet.  Future years will show whether the prevalence of campylobacteriosis in ET 
will reach the average of the state or drop below it. 
 A marked seasonal pattern in the prevalence of campylobacteriosis was observed.  
A peak occurred each summer, which is consistent with the findings of several other 
published studies[4, 204, 231, 242, 243].  A study in Alberta and Newfoundland-
Labrador, Canada found that there was a non-linear association between the ambient 
temperature and the case counts of reported campylobacteriosis[306].   For every degree 
increase in the mean weekly temperature, the number of cases of campylobacteriosis 
reported increased by 6% in Alberta and 4.5% in Newfoundland-Labrador.  Another 
study that analyzed surveillance data from 15 countries in Europe, New Zealand, 
Australia and Canada, found that all countries showed a distinct seasonality and that 
countries with a milder winter were more likely to have a spring peak in the prevalence of 
campylobacteriosis[307]. 
 The increase in the reported prevalence of campylobacteriosis during the warmer 
summer months may be due to an increase in risky behavior (hiking, camping, fishing or 
swimming) during the summer months.  Outdoor activities, especially recreational water 
exposure, put the population at a greater risk for Campylobacter infections; since these 
activities bring the population into closer proximity with possible sources of infection, 
such as untreated water.   Another reason for the summer increase in the prevalence may 
be an increase in the number of outdoor barbecues which could lead to an increase in the 
consumption of under cooked meat or greater opportunity for cross contamination of 
foods.   
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 The highest peak in the prevalence of campylobacteriosis in East Tennessee 
occurred in the summer of 2003, the same year as the highest annual prevalence for the 
study.   Identification of seasonal patterns among residents of ET can assist health 
department personnel in directing their scarce education resources and timing prevention 
efforts to have the greatest impact.   
5.1 Strengths and Limitations 
 Under reporting of campylobacteriosis is a limitation of this study.  There are 
numerous steps (Figure 2.1) that must be taken in order for a case to be reported and be 
entered into the surveillance database.    As such, not every case of campylobacteriosis 
that occurred in ET is included in the database of this study.  In addition, the proportion 
of cases that go unreported may not be the same for all age, sex and socioeconomic 
groups and geographic locations.  So it is possible that certain population groups are over 
or under represented in the prevalence estimates.  The differences in population groups 
that are reported may be due to differences in access to medical care and laboratory 
facilities, physician practice and patient compliance of each group.  It is possible that 
doctors in rural areas may be less likely to request a stool sample due to the distance to 
the nearest laboratory, adults may be less likely to comply with a doctor’s request for a 
stool sample due to their schedule, or less likely to comply with the request if their 
symptoms improve before sample collection, and some patients may be less likely to visit 
a doctor if their symptoms are not as serious.  A Canadian study of physician practices 
found that doctors were more likely to request a stool sample if the patient reported 
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bloody diarrhea, recent overseas travel, an immunocomprised status or a duration of 
illness >7 days[308].  In that study physicians indicated that laboratory availability, the 
time required to get a laboratory diagnosis and cost also influenced their decision to 
request a stool sample.  Regional differences in patient behavior and physician practice 
that affect disease reporting can make comparing the prevalence of campylobacteriosis in 
ET to other states and other countries difficult.  These differences could include the more 
rural nature of ET that might indicate fewer diagnostic laboratories that are located a 
greater distance from the patients compared to other parts of the US.  A big difference 
between the US and other countries is the difference in health care systems; countries 
with universal government funded health care may have higher rates of reporting since 
more patients have health insurance and are therefore able to visit the doctor.  However; 
if surveillance system stable over time, reported prevalence can identify trends in true 
prevalence. 
 Another limitation of this study is that the data collected on clinical symptoms, 
and risk factors were self reported and voluntary.   For other variables the data were not 
collected in a standardized manner, such as information on the health status of the animal 
the patient was exposed to or the treatment protocols of the private household wells; the 
information was recorded for some patients, but not for all.  In some cases the respondent 
could not supply the information requested, therefore, unknowns and missing information 
occurred frequently for some variables.  The missing information could lead to biased 
results if patients that did not provide the requested information were systematically 
different from the rest of study patients.   
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 A strength of this study is that the data used were collected through active 
surveillance; this means that every stool culture that was positive for campylobacteriosis 
should have been reported to the health department.  While the number reported is lower 
than the actual total number of campylobacteriosis cases that are occurring in the region, 
all cases identified during the study period were included in the study database, so the 
prevalence calculated should reflect the trends that are occurring in the prevalence of 
campylobacteriosis in ET.  The data storage system and case report form changed during 
the study period, but the law governing disease reporting did not.  While the wording of 
some of the risk factor variables changed, the basic information collected did not change 
over the 4 years of the study.  All errors that were created by the change in the database 
structure in 2004 were corrected before analysis was conducted so this should not 
influence the conclusions either.  Since all cases were reported to the health department 
in a similar fashion throughout study period, the data within ET can be compared across 
years of the study. 
 Another strength of this study was a data quality evaluation that was performed 
prior to analysis.  Often the data obtained through surveillance systems is assumed to be 
accurate.  The data quality evaluation of the data used in this study showed that the 
average error rate (6.5%) was within the range of error rates from other evaluations of 
computerized records[267].  This evaluation shows that the data used in this study is 
primarily accurate, can be trusted and can be used to analyze the trends of 
campylobacteriosis in ET. 
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5.2 Conclusions 
 In East Tennessee the reported prevalence of campylobacteriosis is declining.  On 
average, the prevalence is lower than that reported in all of the FoodNet sites within the 
United States.  However, the annual prevalence is, on average, 1.6 times higher than the 
whole state of Tennessee.  Several counties (Grainger, Jefferson, Union, Blount, and 
Loudon) in the region have an average annual prevalence that is much higher than the 
regional average and some are higher than the national average.  Similar to other studies, 
a large spike in the prevalence of disease occurred during the summer months.   
 The highest age-specific prevalence (41.57/100,000) was observed in young 
children under 5. This is higher than the prevalence for the same age group in the rest of 
the United States (24.01/100,000).  The median age was lower in the more rural counties; 
children comprise a larger percentage of the cases in these areas than the urban ones.  
 While the quality of the data used in this study was within the range of previously 
published reports on data entry rates, some patterns were identified that affected data 
quality in this study.  Changes in the database storage system, in 2004, affected data 
integrity.  With the current database storage system, further errors such as these are not 
likely to occur.  It was also noted that several patients were assigned a race or ethnicity in 
the computer dataset, when none was indicated on the paper case report form.  In order to 
ensure the accuracy and integrity of the dataset, more care needs to be taken when 
transcribing information from the data collection form to the electronic database. 
 A larger percentage of campylobacteriosis patients were hospitalized in ET, but 
the LOS was shorter for patients in this study than the rest of the US and other countries.  
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Unlike what has been reported in other countries, the percentage of cases hospitalized, in 
this study, varied with the season, the highest percentage occurred in the summer.  
 The clinical characteristics of patients in this study were largely similar to those 
of other published reports.  Almost all patients experienced diarrhea (97.5%) while only 
37.8% reported blood in their stool, which is comparable to worldwide reports.  Bloody 
stool was found to be significantly associated with age; young children had much higher 
odds of reporting this symptom than the rest of the population.  Fever and cramps, 
however, were reported less frequently in this study than other parts of the US.   
 The most commonly reported risk factor was recent animal exposure, with young 
children 3 times more likely to report animal exposure than adults over 50.  Other 
hygiene related risk factors (handling raw meat, a household member in daycare) were 
associated with age as well. Almost a third of the cases reported a well as the drinking 
water source of the household; this was higher in the more rural counties and among 
young children.   
 No factor or factors were identified that would explain why the prevalence of 
campylobacteriosis is higher in East Tennessee than the rest of the state.     
5.3 Recommendations and Future Research 
5.3.1 Recommendations to the Health Departments 
• Focus education programs on areas of high risk, especially Grainger and Jefferson 
Counties.  These programs could include school presentations or pamphlets 
focusing on hygiene (especially around animals).  Pamphlets could also be 
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developed for distribution to parents on how to make hand-washing fun for 
children.  These “games” could be distributed as posters to childcare centers and 
nursery schools to encourage thorough hand-washing.  This information could 
also be included on a regional health department website with links to some of the 
many internet resources already available.    
• In store education could be coordinated with area grocery stores to provide 
displays emphasizing the need to keep raw meat (and its juice) separated from 
other foods in the grocery cart, in the refrigerator and during preparation  
• Promote private well protection and treatment information.  
• Set a definition for the animal exposure risk factor and collect more information 
on the type of exposure (occupational, live on a farm, school trip, household pet 
or pet of a friend, or animal sleeps in bed), or average length of exposure to better 
quantify the animal exposure and possible Campylobacter transmission.   
• Target altruistic and church groups with educational information for travelers to 
rural areas or international destinations where acquiring campylobacteriosis may 
be more common to ensure these groups are aware of the possible exposures for 
Campylobacter spp. and other enteric pathogens.   Information has been by the 
CDC and this information could be assembled in a pamphlet or power 
presentation and given to groups that routinely travel overseas such as churches.   
• Improve quality of surveillance data through more thorough collection and 
accurate data entry. 
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5.3.2 Future Research 
 In order to better understand the prevalence of campylobacteriosis in household 
pets of East Tennessee, a study should be conducted to randomly sample animals in their 
normal habitat for the presence of all thermophillic Campylobacters.  The study would 
investigate dogs that have frequent contact with other dogs to determine the prevalence of 
Campylobacter spp.  This could be studied by routinely sampling dogs at parks or other 
areas where dogs frequently come in contact with each other.  High prevalence of 
campylobacteriosis amongst the dogs at each park may be used to justify rules governing 
the pick up and sanitary disposal of dog feces in parks, and could be used to educate the 
public about Campylobacter transmission. 
 Since there is a large percentage of the patients in this study that have a well as 
the source of water for the household, a survey of wells in the region should be conducted 
to test for contamination.  This survey could also include repeat sampling after periods of 
heavy rain to investigate if Campylobacter is washed into well water with rain water 
runoff. 
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Appendix A 
Information Obtained by East Tennessee Regional and Knox County 
Health Departments on Campylobacteriosis Case Report Forms 
 
A.1 Information collected on campylobacteriosis case report form used 
from 2003-2005 
 
Demographics 
Full name 
Complete address 
Phone number 
Date of birth 
Sex 
Race (white, black, native-American, Asian/pacific islander, unknown) 
Ethnicity (Hispanic, non-Hispanic, unknown) 
Employer, School, Daycare or After-school center attended 
 
Clinical Data 
Date/Time of symptom onset 
Symptoms (diarrhea, bloody stool, fever, headache, nausea, vomiting, cramps, muscle 
aches, fatigue, other) 
Duration of symptoms 
Treatment 
Physician visit (doctor’s office, urgent care, emergency room, none) 
 Physician name 
Hospitalized (yes, no, unknown) 
 Hospital name, Admission date, Discharge date 
 
Laboratory Data 
Specimen source (stool, blood, urine, none, other) 
Date of sample collection 
Laboratory test conducted (culture, ova & parasite, serological, other) 
Name of the reporting laboratory 
Date of laboratory report 
 
Exposures 
Travel to another state or country in the two weeks prior to onset? (location, date) 
Contact with any animals? (list) 
Handle raw meat/poultry? (yes, no, unknown) 
Household member in daycare? 
Contact with person with similar symptoms? 
Hike, camp, fish, or swim? 
Drink from a spring, stream, or lake? 
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Household water supply (city, well, spring, other) 
 
List of household members (age, relationship, symptomatic, date of onset, also tested, 
occupation) 
 
Food History for 3 days prior to onset of symptoms 
List of restaurants dined at 1 week prior to onset of symptoms 
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A.2 Information collected on campylobacteriosis case report form, 2006 
 
Demographic 
Full Name 
Date of Birth 
Reported Age 
Sex 
Full Address 
Phone Number 
Ethnicity (Hispanic, not Hispanic) 
Race (American Indian/Alaskan, Asian, Black/African American, Hawaiian/Pacific 
islander, White, other) 
Employer/School/Daycare 
Occupation 
 
Laboratory Report 
Reporting facility 
Ordering facility 
Ordering provider 
Laboratory report date 
Date received by Health Department 
Specimen source (blood, stool, cerebral-spinal fluid, urine, other, unknown) 
Date sample collected 
 
Clinical Information 
Physician 
Was the patient hospitalized for this illness? (yes, no, unknown) 
 Hospital, Admission date, Discharge date 
Diagnosis date 
Is the patient pregnant? 
Did the patient die from this illness? 
 
Epidemiologic Information 
Is this patient associated with a daycare facility?  
Is this patient a food handler? 
Is this case part of an outbreak? 
Where was the disease acquired? (indigenous, out of jurisdiction, out of state, out of 
country, unknown) 
Transmission mode (foodborne, waterborne, zoonotic, indeterminate, other) 
 
Symptom History 
Date/Time of illness onset 
First symptoms 
Symptoms (abdominal cramps, backache, bloody diarrhea, chills, constipation, diarrhea, 
fatigue, fever,  headache, muscle aches, nausea, vomiting) 
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Date/Time of recovery 
Duration 
 
Travel History 
Did patient travel prior to onset of illness? 
Type (domestic, international) 
Destination (date of arrival, date of departure) 
Mode of travel (airplane, bus, car, cruise, ship, train) 
 
Related Cases 
Does the patient know of any similarly ill persons? 
Are there any other cases related to this one?  
 
Possible Source(s) of Infection During Exposure Period 
Consumed any poultry? Undercooked? 
Handled raw poultry 
Consumed food at a group meal  
Consumed food from restaurants 
Contact with diapered children 
Contact with any other persons having diarrhea 
Occupational exposure to human or animal excreta 
 
Drinking Water Exposure 
Household water source (do not use tap water, municipal or city, private well, other, 
unknown) 
 If private well, how was the well treated? 
What is the source of tap water at school/work? 
Did the patient drink untreated water in the 7 days prior to onset of illness? 
 
Recreational Water Exposure 
Was there recreational water exposure in the 7 days prior to illness? 
  (hot spring, hot tub-whirlpool-jacuzzi-spa, interactive fountain, lake-pond-river-
stream, ocean, recreational water park, swimming pool, other, unknown) 
 
Animal Contact 
Did the patient visit or live on a farm? 
Did the patient visit a live animal exhibit? 
Dif the patient come in contact with any animals? 
Type of animal (cat, cattle, chicken, dog, goats, lizard, other, other amphibian, other 
mammal, other reptile,  rodent, sheep, turkey, turtle, unknown) 
Location of animal contact 
Did the patient acquire a pet prior to onset of illness? 
 
Patient Prophylaxis/Treatment 
Was the patient treated with any antibiotics for this illness? 
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A.3 Variables included on the campylobacteriosis case report form that 
were added to the electronic dataset  
 
Laboratory test ordered (stool culture, ova and parasite, serological) 
Date of onset 
Clinical symptoms (yes, no; fever-specific temperature) 
Duration of symptoms 
Treatment 
Location of physician visit 
Animal exposure 
Other risk factor exposures (raw meat, other cases, daycare, outdoor activity, drinking 
 untreated water) 
Household water source (well, city, spring, other) 
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A.4 Variables present in the electronic campylobacteriosis datasets 
obtained from the East Tennessee Regional and Knox County Health 
Department 
 
Variable* Years in the dataset 
City All 
Address 2003-2004 
State All 
County All 
Zip code All 
Birth date All 
Age All 
Race All 
Ethnicity All 
Gender All 
Serotype 2004-2006† 
Specimen source All 
Date of specimen collection/diagnosis date All 
Date reported All 
Outcome All 
Patient Status (hospital, outpatient, unknown) All 
Patient hospitalized? 2003, 2005-2006 
Hospital name 2003-2004 
Admission and discharge dates All 
Travel 2004-2006 
Destination and travel dates 2005-2006 
Reporting laboratory name 2004-2006 
*
 Some variables, that had no pertinent information to this study, were excluded from the 
list 
†
 Some information on serotype was collected in 2003 in the “other” variable field, but 
data were incomplete   
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A.5 New variables created from information provided on the 
campylobacteriosis case report form 
 
Antibiotic prescribed (yes, no, unknown) 
Class of antibiotic 
Intravenous fluids given (yes, no, unknown) 
Anti diarrheal or anti nausea medication given (yes, no, unknown) 
Number of treatments 
Age group 
Severity (mild, moderate, severe) 
Time waited before seeking medical care 
Days spent in hospital (Length of stay) 
Season 
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Appendix B 
Counties Groupings Determined by Urbanicity and Prevalence of 
Campylobacteriosis Created for Analysis 
 
 
B.1 Groupings of the study region based on the urbanicity of the county  
 
Grouping Percentage of population living in an urban area 
Group 1 (66% or more)  
     Knox County 87% 
     Hamblen County 75% 
Group 2 (44 – 66%)  
     Blount County 63% 
     Anderson County 58% 
     Roane County 51% 
     Loudon County 50% 
Group 3 (22 – 44%)  
     Campbell County  43% 
     Sevier County 35% 
     Cocke County 33% 
     Claiborne County 30% 
     Jefferson County 25% 
     Monroe County 23% 
Group 4 (0 – 22%)  
     Morgan County 18% 
     Scott 15% 
     Grainger 0% 
     Union 0% 
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B.2 Groupings of the study region based on the prevalence of 
campylobacteriosis in the county  
 
Grouping Age- and Sex-Standardized  
Mean Annual Prevalence  
(cases/100,000 population) 
Group 1 (0 – 6 cases/100,000 population)  
     Hamblen County 3.8 
     Roane County 4.4 
     Scott County 5.1 
     Morgan County 5.7 
Group 2 (6 – 12 cases/100,000 population)  
     Campbell County 7.1 
     Sevier County 7.6 
     Cocke County 8.7 
     Claiborne County 8.8 
     Anderson County 9.3 
     Monroe County 9.3 
     Knox County 11.8 
Group 3 (12 – 18 cases/100,000 population)  
     Loudon County 13.1 
     Union County 14.0 
     Blount County 15.6 
Group 4 (18 – 24 cases/100,000 population)  
     Jefferson County 21.8 
     Grainger County 22.9 
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B.3 Map of the counties in the study region grouped based on the age- and sex-standardized prevalence of 
campylobacteriosis 
 
 164 
Vita 
 
 
 Karissa Dawn Laughter was born in Portland, Oregon on April 19, 1981.  She 
graduated from Half Moon Bay High School in 1999.  Karissa attended the 
Massachusetts Institute of Technology in Cambridge, MA and received her BS in 
Biology with minors in Biomedical Engineering and Chemistry in 2003.  She spent two 
years in rural Paraguay serving with the Peace Corps in the Beekeeping Extension 
program.  She attended graduate school at the University of Tennessee in Knoxville, TN 
and received her Masters in Comparative and Experimental Medicine with a minor in 
Statistics in 2008.   
